Safe Medication Administration and Error Reduction
Error reduction, the rights of medication administration, DEA drug schedules, evidence-based practice, and the legal, ethical & cultural foundations of giving medications safely.
Overview & the Nurse's Role
The Prescribing Relay — Who Hands Off to Whom
MD/DO, APRN, dentist, or PA — H&P, diagnose, prescribe, monitor, modify. Authority varies by state.
Knows federal/state/facility policy, safeguards & stores meds, calculates doses accurately.
Verifies accuracy, follows legal mandates for controlled substances.
Evaluates response, reports all errors — last safeguard before the client.
Nursing students cannot accept verbal or telephone prescriptions — only a licensed nurse may, and only for true emergencies, following facility protocol.
Medication Nomenclature — One Drug, Three Labels on One Bottle
Molecular structure. isobutylphenylpropanoic acid
Nonproprietary — only one per drug (US Adopted Names Council). ibuprofen
Brand name — a drug can have multiple. Advil, Motrin
Controlled vs. Uncontrolled Substances
Generally no misuse/addiction risk.
Misuse/dependence potential (I–V). Higher schedule number = lower risk. See DEA Schedules ↓
FDA Regulations
Rigorous testing for efficacy/safety — can still have unidentified adverse effects.
Nurses report unreported ADRs to MedWatch on the FDA site.
3 label sections: pregnancy, lactation, reproductive potential.
Always verify safety for a client who is/could be pregnant.
10 Rights of Medication Administration
Nurses are the last safeguard before a medication reaches the client. ~7,000 U.S. deaths/year are linked to nurse-related medication administration errors, costing an estimated $3.5 billion annually.
Think of the 10 rights as links in one chain — break any single link, and the whole safety chain fails.
2 identifiers (Joint Commission) — name + DOB/ID#. Check ID band, allergies, barcode scan.
Compare label to MAR 3 times. Leave unit-dose meds packaged until administration.
Unit-dose systems; check a reference range. Double-check high-alert meds (insulin, heparin).
Time-critical: ±30 min. Once-daily: within 2 hr. >1×/day (≤q4h): within 1 hr.
PO/SUBQ/IM/IV/topical + SL, epidural, intrathecal, PCA, enteral. Separate syringes for enteral vs. parenteral.
Record med/dose/route/time/response immediately after — never before.
Purpose, what to expect, how to take it, what to report — individualize.
Respect refusal → explain consequences → inform provider → document.
Collect data before/after — e.g., apical pulse before digoxin.
Follow up to confirm the therapeutic effect happened & adverse effects didn't.
Client says "I don't want one more pill" before digoxin → best response: "Tell me your concerns about taking this medication." (open-ended, explores refusal before acting.)
Medication Prescriptions & Reconciliation
Types of Prescriptions
Ongoing, scheduled dosing.
Given once.
Immediately, one time.
As needed, per client status.
Components of a Prescription — Required Field Checklist
| Client | Full name, date & time written |
| Medication | Name (generic/brand), strength & dosage |
| Sig | Route, time/frequency of administration |
| Dispense | Quantity + number of refills |
| Signed | Prescribing provider's signature |
| + if controlled | Client DOB & address, provider's DEA number, directions for use |
| Never required | ✕ insurance info, ✕ preferred pharmacy |
Medication Reconciliation — When It Happens
Compile complete list incl. OTC & supplements.
Unit-to-unit or facility-to-facility.
Reconcile + resolve discrepancies w/ provider.
Required by The Joint Commission — continually reviewed/updated throughout care to prevent errors & adverse interactions.
Build a comprehensive list incl. OTC/supplements and verify it with the client's pharmacy records — don't rely on memory, and don't defer the whole task to pharmacy.
Verbal/telephone prescriptions: emergencies only, per facility protocol, with "read-back" verification (receiver repeats it back to confirm accuracy).
Knowledge Required Before Administering
| Category / Class | Action + use + body system + pregnancy class. Lisinopril = ACE inhibitor, antihypertensive. |
| Mechanism of Action | How it works. Glipizide → pancreas releases insulin. |
| Therapeutic Effect | Expected response, can be >1. Diphenhydramine: allergy relief or sleep aid. |
| Side Effects | Known/expected, mild. Antibiotics → diarrhea. |
| Adverse Effects | Unexpected, harmful. Gentamicin → hearing loss. |
| Toxic Effects | Prolonged use/impaired clearance. Digoxin + hypokalemia → cardiotoxicity. |
| Interactions | Beneficial or harmful. Omeprazole + phenytoin → ↑ phenytoin level. |
| Contraindications | Tetracyclines stain teeth <8y; myasthenia gravis + fentanyl. |
| Prep / Dosage / Route | Oral morphine > parenteral dose (first-pass effect). |
| Nursing Implications | Monitor, prevent/treat ADRs, comfort, educate. |
Adverse Drug Reactions (ADRs) — Severity Gauge
- Unwanted/unintended response at a therapeutic dose
- Prior exposure ↑ sensitivity → more severe reaction on re-exposure
- Ask open-ended Qs: onset, current meds, dose/route/frequency, reaction history
- Implement provider-directed care: stop med, treat, or change med
- Document & notify provider per policy
Most urgent ADR finding to report: facial edema + dyspnea (anaphylaxis warning signs) — more urgent than mild itching, isolated dyspnea, or positional dizziness.
Medication Error Prevention
A sentinel event = any medication error that results in client harm (temporary or permanent) or death. Errors can happen at any phase: provider prescribing, pharmacy transcribing/dispensing, or nurse preparing/administering. Nurses spend an estimated 40% of their shift in the medication administration process.
Common Medication Errors
Common Contributing Factors
Data-collection resources for medication knowledge: providers/pharmacists/colleagues, Poison Control (1-800-222-1222, 24/7), nursing pharmacology textbooks, the Physicians' Desk Reference, professional journals & websites — not drug-company sales reps.
Look-Alike / Sound-Alike (LASA) — Confused Medication Name List
ISMP + FDA maintain official lists: the Error-Prone Abbreviation List, the Confused Medication Name List, and the High-Alert Medication List. Tall-man lettering highlights the distinguishing syllables.
| Established Name | Recommended (Tall-Man) Form |
|---|---|
| acetohexamide / acetazolamide | acetoHEXAMIDE / acetaZOLAMIDE |
| bupropion / buspirone | buPROPion / busPIRone |
| chlorpromazine / chlorpropamide | chlorproMAZINE / chlorproPAMIDE |
| clomiphene / clomipramine | clomiPHENE / clomiPRAMINE |
| cyclosporine / cycloserine | cycloSPORINE / cycloSERINE |
| daunorubicin / doxorubicin | DAUNOrubicin / DOXOrubicin |
| dimenhydrinate / diphenhydramine | dimenhyDRINATE / diphenhydrAMINE |
| dobutamine / dopamine | DOBUTamine / DOPamine |
| glipizide / glyburide | glipiZIDE / glyBURIDE |
| hydralazine / hydromorphone / hydroxyzine | hydrALAZINE / hYDROmorphone / hydrOXYzine |
| medroxyprogesterone / methylprednisolone / methyltestosterone | medroxyPROGESTERone / methylPREDNISolone / methylTESTOSTERone |
| mitoxantrone / nicardipine / nifedipine | mitoXANTRONE / niCARdipine / NIFEdipine |
| prednisone / prednisolone | predniSONE / prednisoLONE |
| risperidone / ropinirole | risperiDONE / ROPINIRole |
| sulfadiazine / sulfisoxazole | sulfADIAZINE / sulfiSOXAZOLE |
| tolazamide / tolbutamide | TOLAZamide / TOLBUTamide |
| vinblastine / vincristine | vinBLAStine / vinCRIStine |
High-Alert Medications
If given in error → high risk of significant harm. Safeguards: limit access, auxiliary labels, automated alerts, standardized prep, and independent double-checks.
- IV adrenergic agonists/antagonists (epinephrine, propranolol)
- General anesthetics, antiarrhythmics, anticoagulants
- Chemotherapeutic agents (parenteral & oral)
- Hypertonic dextrose (≥20%); dialysis solutions
- Epidural/intrathecal meds; oral hypoglycemics
- IV inotropes (digoxin, milrinone); liposomal drugs
- Moderate sedation agents (IV & pediatric oral)
- IV/oral narcotics; neuromuscular blockers
- Hypertonic saline (>0.9%); TPN solutions; thrombolytics
- Epinephrine SUBQ; epoprostenol IV
- Heparin (LMWH & unfractionated IV)
- Insulin (SUBQ & IV); lidocaine IV
- Magnesium sulfate injection
- Methotrexate (oral, nononcologic)
- Opium tincture; oxytocin IV
- Nitroprusside; potassium chloride/phosphates injection
- Promethazine IV; vasopressin; warfarin
Medication Error Classifications — The Swiss Cheese Model
Every safeguard (knowledge, rules, attention) is a layer of "cheese" with its own holes. A single hole rarely causes harm — an error only reaches the client when the holes in every layer happen to line up at once.
Missing learning about meds, history, or administration. E.g., not double-checking documented allergies. Prevent: verify ID bands, use BCMA, double-check dispensing.
Failure to follow standards of practice. E.g., IM injection in the wrong anatomical site.
LASA confusion or distraction. E.g., a coworker interrupts mid-task → wrong client's med pulled.
When holes in every layer align at once, the error reaches the client.
Distractions That Open "Activity-Based" Holes
Barcode (BCMA) Barriers
| Barrier | Example | Potential MAE |
|---|---|---|
| Missing label | Med dispensed without a barcode | Wrong med; wrong dose |
| Wrong dose dispensed | Whole blister pack vs. 1 tablet | Wrong dose |
| Scanning failure | Unreadable barcode | Wrong med; dose; route |
| Label detached | Label in drawer, not on med | Wrong medication |
| Misplaced stock | Med not placed in drawer correctly | Wrong med; wrong time |
Nursing Process to Prevent Errors
Know the meds you give; gather diagnoses/conditions affecting administration; get baseline vitals/labs; verify the prescription is complete & interpretable — clarify with the provider if unclear; question abrupt/excessive dosage changes.
Identify client outcomes; set priorities for which meds/treatments come first.
Avoid distractions; one client at a time; check label vs. MAR; double-check high-alert doses with a colleague; take the MAR to bedside; never administer meds someone else prepared; secure controlled substances + witness disposal; don't leave meds at bedside.
Evaluate & document response; compare expected vs. actual outcomes; identify/report adverse effects; notify the provider of all errors & implement corrective action immediately.
Incident Reports
- Client identification
- Name & dose of the medication
- Time & place of the incident
- Accurate, objective account of the event
- Who was notified + actions taken
- Your signature
- Complete within facility's time frame — usually 24 hr
- Never reference/include the report in the client's medical record
- Errors relate to systems, procedures, product design, or practice patterns — used to drive process change, not punishment
IV meds have a higher error rate than oral meds (reconstitution + LASA vials). Independent double-checks reduce errors by an estimated 93%.
Communication & Interprofessional Collaboration
ISBARR Hand-Off — As a Radio Call
Identify yourself, your role, and the client.
Purpose of the call/report & the client's current status.
Significant medical history, diagnosis, medications, procedures.
Vital signs, pain rating, clinical concerns, labs, I&O.
Ask about care needs: testing, medication changes, etc.
Read information back to confirm & clarify.
Telephone orders require "read-back" verification — the receiver repeats the order back to the source before transcribing.
Health Care Team Roles
Writes clear Rx w/ diagnoses, allergies, current meds, dosage, frequency, route, duration; considers liver/kidney function.
Reviews allergies, dosages, interactions & contraindications; flags discrepancies immediately.
RN initiates education; PN reinforces it. PN scope varies by state.
Vitals, ADLs, nonpharm support — not meds or education.
Teach-Back Method — A Closed Loop
Plain language, "chunk and check".
In their own words, return demonstration.
Re-teach gaps — not a test, allow handouts.
Use with every client, every time — consistency catches misunderstandings before they become errors.
- Open communication
- Team-based approach
- Holistic care
- Team-based client rounding
- Interprofessional education (in-services, mock scenarios)
Interprofessional collaboration must stay within each profession's scope of practice (e.g., only APRNs consult on prescribing). Discuss client cases using de-identified information to stay HIPAA-compliant.
Culture of Client Safety — "TLC Just CC and L"
- Teamwork — cross-profession collaboration
- Leadership — nurtures safety culture
- Care (EBP) — best-evidence care
- Just Culture — no-fear reporting
- Client-Centered — needs/values first
- Communication — clear, open, two-way
- Learning — continuous improvement
Prioritization, Delegation & Time Management
Administration Time Windows
Five Rights of Nursing Delegation
Legal to delegate
Resources/environment
Within their scope
RN oversight + feedback
Clear instructions
Priority Frameworks — Maslow's Pyramid, Built From the Ground Up
ABC always wins first: Airway → Breathing → Circulation — before anything on the pyramid below.
Inpatient acute care, outpatient/ambulatory clinics, schools, home health, nursing homes, even amusement parks/summer camps. Across transitions (admission → transfer → discharge → external transfer) the nurse leads medication reconciliation & communicates with the next care team. ETMs (electronic task management systems) help coordinate medication tasks across the team.
Evidence-Based Practice & Spirit of Inquiry
EBP = best research evidence + clinical expertise + client preferences. Spirit of inquiry = fostering curiosity, organizing support for EBP, using data to improve practice, seeking support from EBP-minded colleagues.
EBP Steps
Ask a clinical question — develop a PICOT question.
Scholarly databases, journals, gov't & policy documents.
Rank by level of evidence; check for peer review.
Change interventions w/ interprofessional buy-in.
Track outcomes, unbiased — report positive & negative findings.
Journals, posters, conference presentations.
PICOT Question Format
Clients in an acute care setting
Computerized physician order entry
Handwritten prescriptions
Reduction in medication errors
1 year
Levels of Evidence — Strongest at the Top
- CINAHL Plus — comprehensive nursing/allied health full text
- Cochrane Collection — systematic reviews & RCT registers
- PubMed — U.S. National Library of Medicine, 30M+ citations
- AHRQ, Science Direct, Scopus, Sigma Repository, PsychARTICLES
- .gov — government agency, trustworthy
- .edu — educational institution, usually trustworthy
- .org — nonprofit; verify the organization
- .com — commercial; may be selling a product
Not credible for clinical evidence: Google, WebMD, personal blogs, commercial product sites.
Disseminating Findings
Peer-review process: author submits → editorial dept. checks requirements → editor-in-chief screens for scope/merit/originality → associate editor assigns ≥2 reviewers → accepted (production) or returned for revision.
DEA Drug Schedules & Controlled Substances
The DEA classifies medications by medical use + dependence potential. Born from the Controlled Substances Act of 1970. States may be more restrictive than federal schedules — never less.
No medical use, high misuse potential. Heroin, LSD, marijuana, ecstasy, peyote
Medical use, high misuse potential. Fentanyl, oxycodone, methadone, cocaine, amphetamine
Moderate–low misuse potential. Ketamine, anabolic steroids, acetaminophen w/ codeine
Less potential than III. Alprazolam, zolpidem, diazepam, tramadol
Least misuse potential. Pregabalin, cough syrup <200mg codeine, diphenoxylate/atropine
Prescribing Rules by Schedule
| Schedule | Refills | Can be called in? |
|---|---|---|
| II | No refills — new written/e-signed prescription required each time | No (except true emergency) |
| III & IV | Up to 5 refills within 6 months of issue date | Yes |
| V | Per state/facility policy | Yes |
| III–V (general) | Limited to a 90-day supply | — |
Schedule II prescriptions must be signed by the provider (written or approved e-signature) — never just phoned in (except emergencies), and never refilled.
4 Considerations to Schedule a Substance
Risk to health/community.
Theft/resale from legal distribution.
Used without one.
Like an already-scheduled drug.
Petitions can come from manufacturers, pharmacy associations, public interest groups, or private citizens.
DEA Registration Number
- Required for any provider who prescribes controlled substances, and for pharmacies that dispense them
- Application requires SSN, the drug schedules they wish to prescribe, state license proof, and background info
- A pharmacy must verify the prescriber's DEA number before dispensing
- State prescription monitoring programs (e.g., NY's I-STOP) track controlled-substance prescriptions to prevent doctor-shopping
Required Elements — Controlled Substance Prescription
✕ Never required: insurance info, preferred pharmacy.
Ethical Principles, Informed Consent & Confidentiality
The 4 Ethical Principles
Accept/refuse care per own values — nurse gives risk/benefit info ("truth-telling") for an informed decision.
Distributive justice — fair allocation of time/meds/equipment, regardless of insurance/status.
Promote best outcome — e.g., timely pain meds, checking swallow ability first.
Guides end-of-life decisions & choosing the med w/ fewest adverse effects.
Informed Consent — UARE Mnemonic
Client understands their condition.
Recognizes there's a significant decision to make.
Can weigh risks vs. benefits.
Can state their decision — even if it's a refusal.
- Client is competent to decide
- Provider fully discloses options/alternatives
- Client understands the procedure
- Decision is made without coercion
- Client consents
- 1. MPOA / Guardian
- 2. Spouse
- 3. Adult Child
- 4. Parent
Client's actions show agreement (e.g., doesn't resist a blood draw they were told about). No consent needed if a client needs lifesaving intervention and can't consent (e.g., CPR, hemorrhage from trauma).
Suffering from a moral conflict between personal values and what's happening in care (e.g., a provider dismisses a client's pain as "drug-seeking"). Each profession has its own code of ethics; reviewing each other's helps interprofessional teams avoid role-related conflict.
Confidentiality & HIPAA
- PHI includes prescription records, admission profile, billing, referrals, discharge/follow-up appointments
- Share PHI only with those directly involved in care, or with client-authorized individuals
- Exceptions without a release: child abuse, fraud, elder neglect, public health law, or life-or-death matters
- Lock/close screens with client info; verbally confirm before discussing meds in front of visitors
- Report violations to a supervisor/privacy officer; escalate if unresolved
Health Equity, Bias & Culturally Competent Care
Social Determinants of Health (SDOH) — 5 Pillars
SDOH account for ~90% of health outcomes vs. 10–15% from medical care alone. ~40–60% of clients are nonadherent to their prescribed regimen.
Cultural Considerations — LARA Mnemonic
To needs & emotions.
Paraphrase what they said.
Clarify uncertainties.
Info for understanding.
- Fasting (e.g., Ramadan) → schedule meds at the breaking-of-fast/evening meal
- Animal-derived ingredients (porcine heparin, gelatin capsules) may conflict with religious beliefs
- Client-centered care: ask about goals, daily routine, role in community before building a med schedule
- Perceptual factors (how they define health) vs. practical factors (transportation, pharmacy access, finances)
Historical Trauma & Bias
The Tuskegee syphilis study (1932–1972) withheld treatment from African American men under false pretenses — a key driver of present-day mistrust in marginalized communities.
Explicit = aware, stated. Implicit = subconscious, unrecognized by the provider.
12.3% of Black respondents vs. 2.3% of White respondents reported health care discrimination. Black clients were 2.54× more likely to have a negative chart descriptor (e.g., "difficult," "non-adherent").
Discrimination (inequitable treatment because of bias) ≠ bias itself (a thought process). ~1 in 5 people report being "hassled or made to feel inferior" in health care — most often racial/ethnic (17.3%), followed by income/education (12.9%), weight (11.6%), sex (11.4%), age (9.6%), and ~3.9% based on medication/substance-use history.
Using Non-Biased Language — Swap the Term
| Avoid | Use Instead |
|---|---|
| Abuse | Use of illicit drugs / misuse of prescription medications |
| Addict / abuser | Person who has a substance use disorder |
| Addicted infant | Infant exposed to substances |
| Clean / dirty (urine) | Tested negative / tested positive |
| Former addict | Person in recovery |
| Medication-assisted treatment | Medication for opioid use disorder |
| "Frequent flyer" | Describe the visit pattern objectively |
Stigmatizing chart labels measurably reduce providers' pain-management aggressiveness. People-first language (e.g., "a person who has diabetes," not "a diabetic") reduces shame — except where a community prefers identity-first language (e.g., some Deaf/autistic communities); always honor client preference.
Reducing Bias — Organizational Tools
- Routine bias reviews of policies, charting, and education materials — often led by a DEI/ad hoc committee with mixed experience levels
- Implicit Association Test (IAT) (Harvard) — self-reflection tool revealing subconscious bias
- Increasing workforce diversity improves outcomes for clients from similarly marginalized backgrounds
Health Equity & Access
Health equity = every client has the opportunity to reach their highest level of health — it requires naming past injustices and removing structural barriers.
Caregiver-administered meds = higher error risk (often under-educated on the regimen).
Six Rights of Medication Administration Communication
A bias-check layer on top of the 10 rights — same idea, applied to communication.
Mini Case Study — Cultural Conflict & Clinical Judgment
Layla, a Muslim preoperative client, is prescribed enoxaparin (porcine-derived) for VTE prophylaxis and declines on religious grounds. Nurse Kevin applies the Clinical Judgment Model:
Client states a religious objection to animal-derived products.
Confirms enoxaparin does contain porcine content.
VTE risk must still be addressed without violating the client's beliefs.
Consult pharmacist → identifies fondaparinux (non-animal-derived alternative).
Provider orders fondaparinux; client is educated on the change.
Teach-back confirms understanding; no adverse effects occur.
~41.8% of clients struggle to interpret medication labels; ~15.8% had an ADR linked to a misunderstanding. Use a professional medical interpreter first, electronic translation second (app-based tools raised satisfaction by 92% in one study), and printed instructions in the client's language to reinforce teaching. Family/informal interpreters are acceptable only with the client's consent.
Exam High-Yield Summary
Best database for anticoagulant evidence
CINAHL Plus — not Google/WebMD/Medline.com
Preventing a dosage error
Verify against the prescription + consult pharmacy if unsure
ISBARR — "Identify" section content
Nurse's own name/role + client's name/DOB
Adopting a new EBP pain protocol
Review research, evaluate outcomes, collaborate with the team before integrating
SATA — preventing an allergic reaction
Ask what they're allergic to · verify vs. prescription · educate on anaphylaxis signs · ask what manifestations occurred previously
SATA — high-quality evidence sources
PubMed · CINAHL Complete · Cochrane Collection (not blogs/commercial sites)
Clinic prioritization by arrival + urgency
See the later-arriving chest pain client first
Most urgent ADR to report
Facial edema + dyspnea (anaphylaxis)
Team-based client education
PN reinforces medication info after the RN's teaching
Task appropriate to delegate to AP
Obtaining vital signs before an antihypertensive — not injections, education, or reconciliation
SATA — time-critical tasks
Pulmonary arterial HTN med · post-transplant immunosuppressant · reassessing after PRN analgesic
Strongest level of evidence
Systematic review of RCTs
First step implementing new EBP guideline
Develop a PICOT question
Most important pre-administration action
Review the chart for known allergies
Time-critical example
Potassium chloride q2h ×3 doses for hypokalemia
Team-based interprofessional discussion
Consider input from all members, including the client
ISBARR — discussing prior labs
Background
Medication reconciliation safety action
Verify the list against the medical record, flag discrepancies
Prioritize by time-critical policy
Scheduled antiarrhythmic for A-fib
SATA — effective interprofessional communication
Use ISBARR · request pharmacist medication review · involve the client in care decisions
Non-biased charting language
"Person in recovery from substance use disorder"
Language barrier + instructions
Provide written instructions in the client's language via a reliable translation service
Schedule V controlled substance
Pregabalin (not diazepam/carisoprodol/methamphetamine)
Equitable medication follow-up policy
Standardized follow-up regardless of income level
SATA — beneficence in action
Assess swallow/route tolerance · consistent anticoagulant timing · antibiotic-adherence education · review history for interactions
SATA — preventing HIPAA violations
Share PHI only with those involved in care · review HIPAA authorization · report violations · confirm before discussing meds near visitors
Best open-ended adherence-planning question
"What is a typical day like for you?"
SATA — culturally sensitive end-of-life care
Honor home-care wishes · use non-animal-derived meds when needed · use encrypted/secure team communication
Beneficence after an adverse effect
Contact the prescriber to report & discuss changes
Cultural competence in dosing schedule
Collaborate to integrate meds with prayer/cultural practice
SATA — SDOH barriers to medication access
Economic stability · proximity to pharmacy · health insurance access (not education level or brand preference)
DEA — true refill statement
Schedule III/IV: up to 5 refills within 6 months
SATA — SDOH adherence barriers
Steady income · transportation access · health insurance availability
Ethical/legal interprofessional collaboration
Follow facility communication/privacy policy
SATA — cultural sensitivity, new immigrant family
Learn basic phrases · ask about cultural health beliefs · ask about traditional remedies (not jargon, not assuming cues are universal)
SATA — minimizing med errors, busy unit
Barcode scanning · quiet administration space · independent double-check
Cultural competence in medication development
Genetic testing tailors treatment for under-represented populations
SATA — required controlled-substance Rx components
Client DOB · provider DEA # · number of refills · client address (not insurance info)
Pediatric dosing safety
Calculate based on the client's most recent daily weight
SATA — factors creating health disparities in research
Overrepresentation of European descent in genomics · underrepresentation of Indigenous/low-income countries · limited older-adult vaccine trial inclusion
SATA — legal/ethical PHI handling
Prescription records = PHI · clients informed of HIPAA rights · PHI includes admission/billing/follow-up records
Correct DEA classification statement
Schedule II = high abuse potential, nonrefillable prescription only
Respecting client autonomy
Inform of benefits/risks, then ask for consent
Pain-management ethical dilemma
Advocate for a reassessment of the pain plan/dosing
SATA — countering historical bias in pain care
Assess each client individually · use objective charting language · educate & invite questions
SATA — true DEA regulation statements
Pharmacy must verify prescriber's DEA # · Schedule III–V can be called in · III/IV refillable ×5 within 6 months
SATA — respecting autonomy w/ new medication
Give risk/benefit info · respect informed refusal · assess competence · educate on administration/adverse effects
HIPAA-compliant interprofessional case discussion
Discuss using de-identified information
Predictor of medication adherence
Positive personal belief in medication + supportive family outcomes
SATA — bias-free 6 Rights of communication
Verify client identity · tailor info to health literacy · document education & understanding
Addressing implicit bias in practice
Self-reflection + education on implicit bias
SATA — fasting-schedule medication plan
Schedule at fast-breaking/evening meal · give non-food-dependent meds before sunrise fast begins · pair with evening routine
Confused client → informed consent
Notify the provider to clarify before proceeding
Demonstrating cultural sensitivity
Ask about the client's cultural health practices & preferences
Perceptual factor in adherence
How the client defines their own health (vs. transportation/finances = practical factors)
SATA — client-centered adherence support
Ask about health goals/community role · collaborate on timing · connect adherence to desired outcomes
SATA — supporting autonomy, new regimen
Give comprehensive med info · assess understanding/competence · educate a surrogate if client lacks capacity
SATA — language-barrier medication teaching
Professional interpreter first · electronic translation if unavailable · printed native-language instructions
ATI Practice Test
Pharmacokinetics & Pharmacodynamics
How medications move through the body (ADME), how they act once they get there (receptors, agonists/antagonists), how they're grouped into classes, and the interactions/adverse effects nurses must monitor.
Overview — PK, PD & Classification
Nurses don't prescribe or fill prescriptions, but understanding what happens to a medication after administration drives correct assessments, client education, and evaluation of effectiveness.
Pharmacokinetics (PK) — "the body acting on the drug"
Site → systemic circulation.
Circulation → tissues/site of action.
Biotransformation, mainly liver.
Clearance, mainly renal.
Pharmacodynamics (PD) — "the drug acting on the body": the effect a medication has when interacting at receptor sites, plus everything that follows at the cellular/molecular level. Etymology: pharma = medication, dynamic = power/force.
Who Decides What a Medication Can Be Sold As
The Center for Drug Evaluation and Research (CDER), part of the FDA, polices prescription & OTC medications (incl. generics, biologics, sunscreens, antiperspirants, dandruff shampoo, fluoride toothpaste). Manufacturers must submit testing evidence; CDER licenses a medication only if benefits outweigh known risks.
What Makes Up a Pharmacological Class
Actual action at the target location.
What happens in the target organ/system/body.
The substance(s) & how they're arranged.
A pharmacological class = a group of agents sharing any combination of these 3 attributes. Development order: identify mechanism (transport/digestion/expulsion/absorption) → dosage/route → side/adverse effects & contraindications → population impact & interactions → compare efficacy to similar medications.
Quick Reference — Common Prescription Abbreviations
| Abbrev. | Meaning | Abbrev. | Meaning |
|---|---|---|---|
| bid | twice per day | IV | intravenous |
| tid | three times per day | Subcut | subcutaneously |
| qid | four times per day | SL | sublingual |
| q (e.g., q8h) | every (e.g., every 8 hr) | PO | by mouth |
| PRN | as needed | NPO | nothing by mouth |
| IM | intramuscular | pc / ac | after meals / before meals |
Absorption
Absorption = moving a medication into systemic circulation. Gastric routes absorb the smallest amount — this is why oral doses of the same drug are often higher than IV doses.
Three Ways Medications Cross Membranes
Most common. High → low concentration, no energy/carrier needed.
Carrier + energy; moves against the gradient.
Needs a carrier, but no energy, no gradient crossing.
The % of a medication that reaches systemic circulation able to exert an effect. IV = 100% bioavailable; oral is lowest (GI destruction + first-pass effect). Most oral absorption happens in the small intestine (duodenum) — villi maximize surface area.
Route-by-Route Absorption Outcomes
| Route | Absorption Outcomes |
|---|---|
| Oral | Slowest enteral route; affected by food, GI pH/motility; lowest bioavailability; some destruction pre-absorption. |
| Sublingual | Quick — highly vascular, lymphatic flow under the tongue; ↓ by excess salivation. |
| Buccal | Slower/sustained — less vascular tissue than sublingual; ↓ by excess salivation. |
| Rectal | Fastest enteral route — highly vascular; fewer environmental factors interfering. |
| IV | Immediate, most predictable — 100% bioavailable. |
| Intramuscular | Faster than subcut, slower/sustained vs. IV; rate depends on muscle size. |
| Subcutaneous | Slower, sustained — adipose tissue has less blood supply; affected by molecule size. |
| Intranasal | Quick (within 30 min); depends on nasal vascularity & disease (rhinitis); limited dose due to small surface area. |
| Inhalation | Large surface area; can be hindered by mucus/surfactant/epithelial lining. |
| Vaginal | Slow absorption of low amounts — sustained levels. |
| Transdermal | Slow & sustained; bypasses GI & first-pass effect; affected by environment. |
- Ionized = hydrophilic, can't cross membranes. Non-ionized = lipophilic, crosses readily.
- Weak acids absorb best in the acidic stomach; weak bases absorb best in the alkalotic small intestine.
- ↓ particle size → ↑ surface area → ↑ dissolution rate → ↑ bioavailability.
- Polymorphic crystal forms vary in solubility/hardness; amorphic meds dissolve faster.
- Solutions absorb faster than tablets; extended-release capsules delay onset — never crush/open them.
- Age ↓ absorption; pregnancy slows it
- Sex — male and female clients vary in absorption rates/properties
- Parkinson's, IBD, GI cancers, cystic fibrosis all impair absorption
- Ethnicity-linked gastric pH & genetic polymorphism vary absorption
- ↓ perfusion to the GI tract (critical illness) → ↓ enteral absorption
- Food in the GI tract, gastric emptying speed, intestinal transit time, and presystemic metabolism all alter the amount absorbed
A postoperative client has morphine sulfate 4 mg IV q6h PRN severe pain (7–10) and oxycodone 10 mg PO q6h PRN moderate pain (4–6). Understanding absorption lets the nurse match the route to the assessed pain severity & how fast onset is needed — IV for severe/urgent pain, PO once pain is more moderate.
Onset = effect begins; peak = maximum intensity; duration = effect persists. Example: oxycodone immediate-release onsets in 10–30 min (duration 3–6 hr) vs. extended-release onsets in ~1 hr (duration 12 hr) — same half-life (3–6 hr), different formulation.
Distribution
Think of the circulatory system as the train track and plasma as the train carrying medication to its site of action. Goal: achieve a therapeutic concentration at the site of action.
Drug enters circulation, partly free / partly bound to albumin.
Only the free fraction can disembark at receptor sites.
Tight junctions screen cargo — only select drugs cleared through.
Therapeutic concentration reached at the site of action.
Protein Binding
- Medications bind to plasma proteins (mainly albumin) or stay free — only free medication can act at receptor sites.
- High protein-binding affinity → slow, sustained release, longer half-life, less toxicity while bound.
- Malnutrition/hypoproteinemia → less albumin available → more free (active) drug → ↑ toxicity risk.
- Displacement risk: a 2nd medication with higher binding affinity can knock a 1st medication off albumin — dangerous if the displaced drug has a narrow therapeutic index.
Client with low serum albumin (malnutrition, liver disease) → monitor closely for toxicity even without knowing every medication's exact binding %.
Blood-Brain Barrier (BBB) — What's Behind the Checkpoint
Tight junctions of brain endothelial cells + astrocytes (regulate crossing) + pericytes (support vessels, filter immune cells, regulate flow).
Transporters, passive diffusion (low MW + lipophilic), or endocytosis (selective, higher-MW meds).
High protein-binding-affinity meds need intranasal or intrathecal routes.
Two Other Barriers Worth Knowing
Gaps wide open — filters blood flow to the fetus more than it blocks medications. Never assume it protects the fetus.
Bars sit tight — protects male reproductive function.
Tissue Permeability: Kidney & liver membranes are easily permeated; CNS tissue is not. Medications that can't permeate readily need transporter assistance.
- Polarity
- Molecular size
- pH
- Protein-binding affinity
- Fluid status
- Protein levels
- Perfusion
- Presence of disease
- Body fat composition
Metabolism & First-Pass Effect
Metabolism (biotransformation) chemically alters a medication so it can be excreted — mainly in the liver, but also kidneys, GI tract, skin, plasma, lungs.
An oral medication absorbed into the portal vein is partly deactivated by the liver before reaching systemic circulation — lowering bioavailability. Meds with a high first-pass effect (e.g., nitroglycerin) are given SL/IV instead, and oral doses are often prescribed much higher than parenteral doses of the same drug.
The 3 Phases of Metabolism
Oxidation, reduction, hydrolysis, cyclization — removes O/H to polarize the molecule. Metabolites still somewhat active. Prodrugs become active here.
Joins another molecule → becomes water-soluble for easier excretion.
Final metabolite/inactive form, ready for excretion. Depot binding can prolong duration of action.
What Alters the Rate of Metabolism
Polymorphism — gene mutations change how a client metabolizes a drug; often shared within an ethnic group.
Infants/children: immature enzymes. Older adults: ↓ liver volume/perfusion → slower metabolism, higher toxicity risk.
↓ perfusion/enzyme production → toxicity. ↓ albumin → more unbound drug. Cholestasis → ↓ clearance → ↑ serum levels.
Not primary metabolism site, but poor renal function impairs plasma protein binding too.
Enzyme inhibition/induction by one drug changes how others sharing the same enzyme are metabolized.
CYP450 — Induction vs. Inhibition
Repeated exposure spins the gear faster → overmetabolism → need higher doses for effect; also overmetabolizes any other drug sharing that enzyme.
Gear jams → the enzyme-dependent drug builds up → toxicity.
CYP450 enzymes carry out ~90%+ of metabolic reactions, mostly in the liver.
Ciprofloxacin inhibits CYP2C19 → amitriptyline (same enzyme) can't be metabolized → toxicity. Miconazole (CYP2C9 inhibitor) + warfarin → ↓ warfarin excretion → ↑ bleeding risk; monitor INR if both must be given.
Clinical relevance: meds with a high first-pass effect + liver disease → watch for decompensation signs (jaundice, confusion, ascites, edema, spontaneous bleeding) and hold meds if present. Lipid-lowering drugs metabolized by the liver can cause rhabdomyolysis in hepatic decompensation.
Excretion (Clearance)
Excretion = the final PK step — removing the medication/metabolites from the body. Primarily renal (glomerular filtration, tubular secretion/reabsorption); also lungs, skin, GI tract.
Two Excretion Pathways
Meds must be hydrophilic to clear directly via the kidneys. Acetaminophen is hydrophilic. CKD → need dose reduction, longer intervals, or smaller doses.
Hepatocytes → bile → gallbladder → small intestine → reabsorbed or excreted in feces. Liver/gallbladder/biliary disease → excretion delays → toxicity risk.
GFR — The Best Indicator of Clearance
↑ GFR → ↑ filtration/excretion. ↓ GFR → ↓ excretion → toxicity risk. Monitor urine output (min. 30 mL/hr), serum creatinine, and creatinine clearance.
pH of Urine — Opposing Effect
Alkaline meds excreted readily; acidic meds reabsorbed (excreted slower).
Acidic meds excreted readily; alkaline meds reabsorbed (excreted slower).
NSAIDs + methotrexate: NSAIDs reduce renal blood flow → ↓ methotrexate clearance → toxicity. Educate clients to avoid NSAIDs during methotrexate therapy. Kidney transporters can be a site of many drug-drug interactions affecting clearance.
Therapeutic Effect, Half-Life, Peak/Trough & the Therapeutic Index
Therapeutic effect (desired effect) = the client experiences the intended result once PK is complete. Insulin → lowered glucose, confirmed by fingerstick + s/s of hyper/hypoglycemia.
Common Lab Tests Tied to Specific Medications
- Epilepsy → antiepileptic serum drug levels
- Hypokalemia + oral KCl → periodic potassium levels
- Anticoagulation → PT, PTT, INR
- Antiarrhythmics → serum electrolytes + cardiac monitoring
Monitor blood glucose, HbA1c, and renal function tests — ACE inhibitors can slow the progression of nephropathy, and these labs track it.
Blood concentration rises after each dose (peak — toxicity check) and falls before the next (trough — subtherapeutic check); each redose happens before the drug fully decays, keeping levels inside the therapeutic range over time.
Half-Life (t½) — % of Drug Remaining
Time for plasma concentration to drop by 50% — driven by clearance (renal/hepatic function).
4–8 hr short half-life — leaves the body fast, MEC can dip between doses. >24 hr long half-life — dosed less often, but higher accumulation/toxicity risk.
Pete (post-op, pain 10/10) has oral oxycodone or IV hydromorphone ordered — the nurse picks IV because it's 100% bioavailable, guaranteeing the full dose reaches circulation immediately.
Peak, Trough & Random Levels
Highest concentration — checks for toxicity risk. Gentamicin peak drawn ~30 min post-dose.
Lowest concentration, drawn right before the next dose — checks for subtherapeutic failure.
Drawn at any point in therapy.
Gentamicin example: narrow range 5–10 mcg/mL; >12 mcg/mL risks ototoxicity/nephrotoxicity.
Therapeutic Range vs. Therapeutic Index
Wide margin between the lowest effective level and the highest safe level. Most meds — don't need routine monitoring.
Toxic dose : therapeutic dose ratio is small — tiny variations risk fatal toxicity or therapeutic failure. Requires close monitoring.
| Level Result | Risk | Example |
|---|---|---|
| Below therapeutic range (trough) | Subtherapeutic — treatment failure, possible resistance | Low vancomycin trough → infection may not clear, bacteria can become resistant |
| Above therapeutic range (peak) | Toxicity | High phenytoin level → impaired speech, altered consciousness, can be fatal if uncorrected |
Receptor Interactions, Tolerance & Withdrawal
Receptors bind ligands (neurotransmitters, hormones, medications). The reaction can increase or decrease cell function — the effect depends on binding length & strength.
The 3 Receptor Actions — Lock & Key
Binds & activates the receptor → therapeutic response. Ex: methadone — slow opioid-receptor action prevents withdrawal without euphoria.
Binds, causes no effect, but blocks other keys from fitting. Ex: naloxone reverses opioid effects; can be overpowered if morphine dose ↑.
Activates some sites while blocking others — weaker effect. Ex: buprenorphine, pentazocine.
3 Types of Antagonism
Binds & prevents other substances from binding that receptor.
Short but lasting bonds → slow, steady block; reversible by raising agonist concentration (naloxone vs. morphine).
Lets the agonist bind too, but decreases its action.
Antagonists/blockers ≠ inhibitors. Inhibitors block enzymes (ACE inhibitors); beta-blockers block beta receptor sites.
Factors Influencing Receptor Interactions
↑ concentration/dosage → ↑ intrinsic efficacy — direct relationship.
How likely a med is to bind a receptor — depends on med + receptor structure. Higher affinity → stronger effect.
Binds only the target receptor → fewer adverse effects. Nonselective meds bind extra sites → more ADRs.
A medication interacting with its particular receptor sites to achieve an intended effect is called selective medication action.
Drug Tolerance — Needing More for the Same Effect
Long-term exposure → ↑ metabolizing enzymes → drug clears faster → needs higher doses for the same effect. A medication titrated to its maximum dose with no therapeutic response signals tolerance.
Opioid receptors stimulated → produce arrestin → blocks G-signaling → receptor endocytosis → tolerance. Up-regulation = more receptor sites appear → also needs more drug.
Prevention: start at the lowest effective dose; for opioids, add non-opioid analgesics + nonpharm pain strategies.
Withdrawal
- Abrupt removal of a tolerated substance → physical response as the body seeks homeostasis.
- Severity/timing depends on length of exposure, amount, and the drug's half-life.
- Common culprits: opioids, benzodiazepines, SSRIs, glucocorticoids.
- Clonidine (alpha-2 blocker) stopped abruptly → hypertensive crisis (life-threatening).
- Tapering + a sedation vacation reduce withdrawal risk in critical care.
Glucocorticoid taper (prednisone 10 mg tabs): 1 tab QID×4 days → 1 tab TID×3 days → 1 tab BID×2 days → 1 tab daily×1 day. Never stop a long-term glucocorticoid abruptly — risk of adrenal insufficiency.
Drug-Drug Interactions — PK vs. PD Impact
One med can inactivate another before circulation; slow gastric emptying (↓ absorption); ↓/↑ cardiac output; compete for protein-binding sites; alter hepatic clearance; change renal perfusion/GFR/tubular function.
Competing for the same receptor (agonist + antagonist given together) or a nonspecific synergistic effect (multiple anesthetics in the OR). Impact scales with how long both meds occupy the receptor together.
Pharmacological & Therapeutic Classification
Medication Classification Example — Lisinopril
| Pharmacological Classification | ACE inhibitor |
| Therapeutic Classification | Antihypertensive |
| Mechanism of Action | Blocks conversion of angiotensin I → angiotensin II → vasodilation + ↓ BP + ↑ sodium excretion → ↓ fluid volume |
| Therapeutic Effect | ↓ High BP → prevents complications (heart attack, stroke, kidney damage) |
| Indications for Use | Hypertension, heart failure, ↓ mortality post-acute MI |
Pharmacological classification ties to mechanism of action; therapeutic classification ties to what condition it's used to treat. Evidence of an ineffective ACE inhibitor: BP stays the same or rises.
3 Levels of "Site of Action" — Zooming In
The area/tissue the med must enter (e.g., the vasculature).
The kind of cell it must enter (e.g., vascular smooth muscle).
The exact target, e.g., a receptor or enzyme.
Other antihypertensive pharmacological classes that share the same therapeutic effect but different mechanisms: ACE inhibitors, ARBs, calcium channel blockers, beta-blockers — all grouped therapeutically under "antihypertensives," but each its own pharmacological class.
Indications for Use & Line of Therapy
An indication is a signal, manifestation, or condition that prompts a recommendation for therapy. One medication can carry several: furosemide is classified as a diuretic to treat a hypertension diagnosis, but is also indicated to help the body shed fluid/edema from heart failure.
Off-Label Use
Prescribing a medication for a purpose, dose, frequency, route, or population not on the FDA-approved label. The FDA approves the medication itself, not how providers choose to use it — off-label prescribing is legal as long as it's backed by sound evidence and documented.
- 21%–32.3% of all prescriptions are off-label
- Lowest: diabetic therapy (~1%)
- Highest: cardiovascular meds (~46%, excl. HTN/lipid drugs)
- Benefit: extra treatment options when standard therapy fails
- Risk: unknown/unproven benefit, no required manufacturer research, higher risk in vulnerable groups
Lisinopril (approved for HTN/heart failure) used to treat diabetic nephropathy & proteinuria. Once a medication/device is FDA-approved, providers may legally use it off-label — but manufacturers may never advertise or promote an unapproved use.
Side Effects, Adverse Effects, High-Alert Meds & Boxed Warnings
Side Effect → Adverse Effect → Anaphylaxis
Antibiotics are the most common class for adverse effects — mostly immune hypersensitivity reactions. A reaction is "significant"/reportable if it causes death, a life-threatening state, hospitalization, permanent impairment, or birth defects.
Common Side Effects (across ages/medications)
Some side effects are serious despite being "expected" (major bleeding, kidney/liver damage). Mitigation: change medications, adjust dose, or take with food to ↓ GI effects.
Risks to the Client — Worked Examples
First-line for HTN → can cause hypokalemia & hyponatremia, minimized with dietary changes.
Commonly causes a cough that may take weeks to resolve — switch antihypertensives if it disrupts daily life.
All lower BP → expect some degree of fatigue & orthostatic hypotension; teach slow position changes.
Anaphylaxis — The Deadliest Adverse Effect
- Onset: minutes to hours after administration
- Manifestations: hives, pruritus, lip/tongue/uvula swelling, ↓ BP, airway narrowing → possible respiratory failure
- ↑ death risk with COPD, asthma, coronary artery disease
- ~10% of all ADRs are immune-related — mild up to severe (angioedema, Stevens-Johnson syndrome, anaphylaxis, cardiovascular collapse)
Nursing Response Sequence
Stop the suspected medication immediately.
Antihistamine for urticaria; epinephrine for angioedema/anaphylaxis.
Report findings & suspected cause.
Reaction details in the medical record.
Client reports the medication as an allergy going forward.
- 175,000 U.S. deaths in 2022 linked to adverse drug events
- Pharmacogenomics — up to ⅓ of ADRs predictable via gene-medication interactions
- Older adults: 2× the ADR rate of younger clients (polypharmacy)
- Nonselective medications → more ADRs
- #1 priority: document allergies completely & accurately
- Avoid unnecessary prescribing (e.g., antibiotics for viral illness)
- Watch for polypharmacy, especially in older adults
- Use EHR/EMAR access to flag interactions early
High-Alert Medications (HAMs)
HAMs have a low therapeutic index — errors aren't necessarily more frequent, but consequences are far more severe. Insulin requires an independent second-nurse dose verification before administration.
Boxed Warnings
- The FDA's highest safety warning — over 400 medications currently carry one
- Usually applies to a whole medication cohort/class, not a single drug
- Meant to notify of serious risk — not an automatic contraindication
- Metoprolol: boxed warning against abrupt cessation → rebound sympathetic activation → ↑ BP/HR/cardiac event risk
- ACE inhibitors: pregnancy is an absolute contraindication
A client on metoprolol 50 mg PO daily is switched to lisinopril after IV metoprolol stabilized a hypertensive crisis — the nurse must anticipate rebound HTN/tachycardia if metoprolol is stopped too abruptly, and confirm no pregnancy before lisinopril starts.
Drug-Drug, Drug-Food & Drug-Condition Interactions
Three Words for "Meds Affecting Each Other"
One agent amplifies another's strength. Beta-blocker + phenylephrine → excess vasoconstriction.
Combined effect = sum of each agent's individual effect. Olmesartan + amlodipine + HCTZ → 95% reach BP <140/90.
Agents cooperate, effect > sum of parts. Thiazide + ARB → better BP control + ↓ CV risk.
Alfred (60, diabetes) takes metformin plus an antihypertensive that contains a diuretic — the provider should monitor his kidney function regularly, since both metformin and diuretics can impact renal function.
Warfarin + enoxaparin (anticoagulant + LMWH) → combined effect creates a markedly higher bleeding risk — a classic additive drug-drug interaction.
+ K-sparing/thiazide diuretics → ↑ hyperkalemia risk · + NSAIDs → ↓ antihypertensive effect · + insulin/oral hypoglycemics → ↑ hypoglycemia risk · + other RAS blockers → ↑ hyperkalemia, hypotension, renal changes. Drug-condition: impaired renal function + ACE inhibitor → worsened renal function.
DDI Categories — Pharmacodynamic vs. Pharmacokinetic
| Type | Mechanism | Example |
|---|---|---|
| PD — Additive | Same effect from both drugs (harmful or beneficial) | Opioid + promethazine → ↑ sedation/resp. depression; ACE inhibitor + CCB → ↓ edema |
| PD — Antagonistic | Opposite effects cancel the benefit | Corticosteroids blunt antidiabetic glucose-lowering — may need ↑ antidiabetic dose |
| PK — Absorption | One drug ↑/↓ another's absorption | PPIs ↓ ketoconazole absorption; antacids chelate & ↓ doxycycline; rifampicin → ↓ digoxin levels |
| PK — Distribution | Protein-binding displacement | Rare, but watch NTI medications closely |
| PK — Metabolism | CYP induction/inhibition changes blood levels | Phenobarbital alters blood levels of calcium channel blockers |
| PK — Excretion | ↓/↑ clearance rate of another drug | NSAIDs ↓ renal blood flow → ↑ methotrexate levels; cholestyramine + mycophenolate → ↓ immunosuppressant exposure |
Naloxone reverses opioid overdose; flumazenil competitively reverses benzodiazepines; neostigmine raises acetylcholine everywhere except past the BBB — must pair with atropine/glycopyrrolate to block unwanted muscarinic effects. Metoclopramide speeds gastric emptying, which speeds the absorption of other oral medications taken alongside it.
Common Drug-Food Interactions
| Food | Medication | Interaction |
|---|---|---|
| Grapefruit | Statins | ↑ risk of muscle pain & rhabdomyolysis |
| Grapefruit | Amiodarone, carbamazepine, cyclosporine, oxycodone | ↑ medication effect → ↑ side-effect risk |
| Grapefruit | Tacrolimus | ↑ nephrotoxicity risk |
| Dairy | Levothyroxine, tetracyclines | ↓ absorption |
| Vitamin K (leafy greens) | Warfarin | ↓ anticoagulant effect with inconsistent intake |
| Tyramine (aged cheese, processed meats) | Linezolid, MAOIs | Hypertensive crisis |
| Alcohol | Metronidazole | Nausea & vomiting |
| Alcohol | Barbiturates, diazepam | ↑ sedation, impaired cognition |
| Alcohol | Acetaminophen, ketoconazole, rifamycin | ↑ hepatotoxicity risk |
Food can help bioavailability too — bile salts improve solubilization of poorly water-soluble drugs. Strategies: avoid the trigger food, time meds around meals, keep intake consistent (vitamin K + warfarin), or reduce amount consumed. Formulation fixes include enteric-coated, delayed-release, and modified-release products.
Clients with hypertension, diabetes, heart failure, hyperlipidemia, or depression, and older adults taking 3+ chronic-disease medications — monitor these clients most closely.
Lithium + sodium compete for reabsorption in the kidneys — a client who ↑ sodium intake while on lithium therapy can develop lithium toxicity from reduced renal elimination.
Drug-Condition Interactions (DDSIs)
DDSIs are unidirectional — disease affects the drug's action, not the reverse. Most common in older adults (multiple comorbidities). Product labels don't always cover every possible condition.
| Medication | Mechanism | Condition | Potential Interaction |
|---|---|---|---|
| Pseudoephedrine | Stimulates α/β sympathetic receptors | Hypertension | ↑ BP |
| Ibuprofen (NSAID) | ↓ prostaglandins → ↓ renal perfusion | Heart failure / GI bleed | Fluid overload, renal injury, ↑ GI bleeding |
| Prednisone | Gluconeogenesis, immunosuppression | Diabetes / immunosuppression / cirrhosis | Hyperglycemia, ↑ infections, hepatic impairment |
Renal disease can make medications more potent & hazardous — most variation is foreseeable and managed by adjusting dosage. Hepatic impairment changes drug-metabolizing enzymes/transporters → ↑ toxicity risk or ↓ effectiveness; advanced age/infection worsen this further.
Exam High-Yield Summary
Beta-blocker mechanism statement
They are competitive antagonists that bind beta receptors
Buprenorphine for opioid use disorder
Partial agonist at mu-receptors — pain relief, ↓ resp. depression/euphoria risk
SATA — minimizing NTI medication risk
Monitor serum levels · reinforce dosing-schedule adherence · assess for early toxicity signs · report adverse effects
SATA — factors to assess for drug-drug interactions, post-op client
GI motility · therapeutic drug levels · urine output
New urticaria after a medication — first action
Notify the provider immediately
High first-pass-effect med — route to bypass it
Intravenous
New urticaria + pruritus after antibiotic — first action
Assess the client's breathing (airway first)
Anaphylaxis-risk medication — report immediately
Rash + swelling of lips/tongue
SATA — older-adult ADR risk factors
Age · genetic profile · previous ADRs · medication selectivity
SATA — true statements on medication effectiveness factors
Receptor-site concentration proportional to effect · selectivity targets the intended receptor · structural compatibility determines binding strength
Pharmacodynamics receptor principle
↑ dosage → ↑ therapeutic effect up to a point, via binding more receptors
Sublingual medication teaching
Let it dissolve completely under the tongue — don't swallow
Sublingual medication — finding affecting absorption rate
Dry mouth
Kidney-metabolized medication, CKD client — key assessment
Adverse effects/complications specific to that medication's toxicity profile
Surgical unit, multiple meds — DDI monitoring focus
Fluid intake & output
NSAID + opioid together — why?
Synergistic effect → enhanced relief at a lower dose of each
CKD client started on methotrexate for RA — first action
Validate the dose against renal-impairment dosing guidelines
High receptor-affinity medication — expected outcome
Binds strongly → more potent effect
Oral diazepam, fasting pre-op client — bioavailability factor
Food (or lack of it) in the stomach at time of administration
SATA — methadone's mechanism
Acts on opioid receptors to prevent withdrawal · slow action eliminates cravings without euphoria · longer duration than other opioids
Altered metabolism from a DDI — key assessment finding
Altered liver function tests
ACE inhibitor mechanism, heart failure client
Enzyme inhibitor — blocks angiotensin I → angiotensin II conversion → ↓ BP
Why oral meds need higher doses than IV
First-pass hepatic metabolism reduces the amount reaching systemic circulation
Highly selective asthma medication — correct client understanding
Targets only asthma-related receptors → fewer adverse effects
SATA — true receptor-interaction factors
Selectivity determines target binding · serum concentration affects PD response · intrinsic efficacy drives cellular change
Preventing opioid tolerance
Administer the smallest effective dose
Factor affecting protein-binding competition (distribution)
Cardiac output
CKD client + high protein-binding medication
↑ toxicity risk from decreased protein availability for binding
SATA — hydrophilic med + CKD considerations
Monitor renal function for dose adjustment · watch for accumulation from ↓ clearance · confirm water solubility/renal excretability
SATA — agonist/partial agonist/antagonist examples
Naloxone (antagonist) · buprenorphine (partial agonist) · methadone (agonist) · pentazocine (partial agonist)
Diphenhydramine + new dizziness/arrhythmia on monitor
Adverse effect — requires immediate intervention
CKD client on an ACE inhibitor — lab to monitor for clearance
Serum creatinine
Pharmacological classification — ACE inhibitor example
Lisinopril
Warfarin — therapeutic monitoring lab
INR
Off-label use — correct example
Using an HTN-approved medication for a different cardiovascular condition not on the label
ACE inhibitor — correct client understanding of action
"This will help my blood vessels relax, lowering my BP"
Warfarin client, high vitamin K intake
Instruct on periodic PT/INR testing — don't eliminate greens or change the dose independently
Lisinopril side-effect teaching
"If my cough disrupts daily life, I may need a different medication"
Warfarin client — food to monitor
Vitamin K–rich foods
Classic high-alert medication example
Insulin
Vancomycin therapy monitoring
Peak & trough levels
Thiazide diuretic — most severe side effect to report
Severe hypotension
ACE inhibitor pharmacodynamics
Inhibits ACE → ↓ angiotensin II production
Medication class lowering BP by inhibiting vasoconstriction
Prevents production of a vasoconstricting chemical (angiotensin II)
SATA — foods linked to common drug-food interactions
Aged cheeses · fresh fruits · steamed vegetables
ACE inhibitor + hyperkalemia — food to avoid
Broccoli
Off-label use — best example
A medication given at a higher dose than FDA-approved for that condition
Hormonal-pathway inhibitor (vasoconstriction) — managed condition
Heart failure
Metoprolol discontinuation teaching
Taper gradually under provider guidance — never stop abruptly
Off-label use — pediatric example
An adult-approved medication prescribed for a child
Pharmacological classifications — purpose
Identify potential side effects/interactions based on therapeutic action
ACE inhibitor + potassium supplement — nursing action
Educate on hyperkalemia signs & report concurrent use to the provider
Classification based on the medication's specific body action
Pharmacologic classification
Renin-angiotensin system inhibitors — managed condition
Hypertension
Enzyme-blocking antihypertensive class
ACE inhibitors
Lisinopril's therapeutic classification
It is an antihypertensive
Lisinopril — lab value to monitor for an adverse effect
Potassium levels
Expected action of lisinopril
Lowering of blood pressure
Hypertensive client on an NTI medication
Monitor serum drug levels regularly to prevent toxicity
ATI Practice Test
Dosage Calculations and Medication Errors
Reading a prescription, converting units, solving dosage problems three different ways, setting IV flow rates, and the technology/history layer — CPOE, BCMA, QSEN, "To Err Is Human" — built to catch errors before they reach the client.
Prescriptions & Time Conversion
Julie is teaching a parent to give their 6-year-old children's acetaminophen 160 mg/10 mL PO q6h PRN after a tonsillectomy — but the parent only knows doses in teaspoons. Reading the prescription correctly, and translating it into units the family actually understands, is the whole job of this section.
Anatomy of a Medication Prescription
| Field | Detail |
|---|---|
| Date & Time | When the order was issued |
| Client Name | Full legal name — one of two required identifiers |
| Medication | Generic name |
| Purpose | Why it's being prescribed |
| Dosage | Amount + frequency (times/day) + concentration |
| Route | PO, IM, IV, SL, PR, topical, etc. |
| Dispensing Info | Quantity, how to take it, refill parameters, warnings (e.g., avoid with food) |
| Signature | Provider's authenticated signature |
Four Types of Prescriptions
Preestablished protocol for specific conditions (e.g., a critical-care asystole protocol). Can be time-critical or non-time-critical.
Immediate, single dose for an emergency — give within 30 minutes. Document administration time on the MAR accurately.
As-needed — specifies dose/route/frequency/conditions (e.g., pain, fever > X). Guided by clinical judgment + client's subjective report + vitals. Document reason & time given.
Given just once — e.g., a pre-operative dose.
Common Order Abbreviations
| Abbrev. | Meaning | Abbrev. | Meaning |
|---|---|---|---|
| bid | twice per day | SL | sublingual |
| tid | three times per day | PO | by mouth |
| qid | four times per day | PR | per rectum |
| q (e.g., q8h) | every (e.g., every 8 hr) | NPO | nothing by mouth |
| PRN | as needed | pc | after meals |
| IM / IV | intramuscular / intravenous | ac | before meals |
| subcut, s.c., SUBQ | subcutaneous | — | — |
12-Hour ↔ 24-Hour (Military) Time
Military time uses 4 digits, no colon, no a.m./p.m. — it eliminates the "is that 5 a.m. or 5 p.m.?" ambiguity. Runs from 0001 (1 min after midnight) to 2400 (midnight).
Exception: after midnight, don't use 0000.
Add 12 to the p.m. hour.
Add 12 to the p.m. hour.
Exception: just drop the colon/pm.
1615 haloperidol IM = 4:15 p.m.; an 8:30 p.m. antibiotic order in military time = 2030.
Measurement Systems & Conversions
The ISMP recommends removing nonmetric measurements (like teaspoons) from prescribing/dosing/administration entirely — but household units still show up in practice, so nurses must be fluent in both metric and household/imperial systems.
Three Systems, One Bridge
Cooking measures — tsp, Tbsp, cup, pint, quart. Familiar to clients, but the least accurate system.
- 1 tsp = 5 mL
- 1 Tbsp = 3 tsp = 15 mL
- 1 cup = 8 oz = 240 mL
- 1 quart = 4 cups = 960 mL
Originated in England — lb & oz (weight), in & ft (length). Still common for U.S. clinical weight/height.
- 2.2 lb = 1 kg
- 1 in = 2.54 cm
- 1 ft = 12 in = 30.48 cm
- 1 yd = 3 ft = 91.44 cm
Base-10 & the preferred clinical system — g/mg/mcg, L/mL, m/cm/mm. Whole numbers or decimals only.
Converting a weight: 10 lb 6 oz → 10.38 lb (6 oz ÷ 16 oz/lb = 0.375 lb → 10.375 ≈ 10.38 lb). Always convert to a single unit before doing dosage math.
Metric Prefix Ladder
Standard Conversion Factors — Memorize These
Conversions are just proportions. To convert 750 mg → g: since 1,000 mg = 1 g, set up 1 g / 1,000 mg = X / 750 mg, cross-multiply, divide → 0.75 g. This same cross-multiply logic underlies every method in the next section.
The metric system's hidden shortcut: 1 kg of body weight ≈ 1 L of fluid volume — so a weight change from a scale can be read directly as a fluid gain/loss. This is exactly how clinicians estimate dialysis fluid removal or diuresis in a client with heart failure, without a separate conversion step.
Administration Routes & Techniques
Enteral — Oral / Sublingual / Buccal
- Sit upright 90° unless contraindicated
- Never crush enteric-coated/extended-release forms
- Give irritants with a little food; avoid grapefruit juice interactions
- Contraindicated: vomiting, ↓GI motility, no gag reflex, dysphagia, ↓LOC
- SL = under tongue; buccal = cheek/gum — both bypass the liver (no first-pass)
- Keep in place until fully dissolved
- No food/drink until dissolved
Topical & Transdermal
- Apply with a glove/tongue blade/applicator — never bare hand
- Wash + dry skin first; surgical asepsis for open wounds
- Painless, limited adverse effects
- Apply to a hairless area; rotate sites daily
- Wash/dry skin before a new patch
- Never cut patches — alters medication delivery
Mucous Membrane Instillation
- Tilt head back, look up; drop into the conjunctival sac from 1–2 cm — never on the cornea
- Press the nasolacrimal duct 30–60 sec to limit systemic absorption
- Wait 5 min between two different eye meds
- Straighten canal: pull auricle up & back (adult) or down & back (child <3)
- Warm drops first — cold can cause dizziness
- Stay side-lying 2–3 min after
- Supine, head positioned toward the target passage
- Breathe through the mouth; no nose-blowing for 5 min after
- Left lateral (Sims') position; insert past the internal sphincter
- Stay flat/left-lateral ≥5 min to retain it
- Modified lithotomy/dorsal recumbent position
- Insert along the posterior wall — 7.5–10 cm for suppositories, 5–7.6 cm for creams/foams
- Stay supine ≥10 min
Inhalation
- Shake 5–6×; exhale first, then a slow 3–5 sec inhale while pressing
- Hold breath 10 sec; exhale through pursed lips
- Wait ≥1 min between same-med puffs
- Do not shake — load per manufacturer directions
- Exhale fully first, then one deep inhale through the mouth
- Hold breath 5–10 sec
Both: rinse mouth/brush teeth after a corticosteroid inhaler (↓ oral fungal infection risk).
MDI With a Spacer — Step Sequence
Remove both mouthpiece covers, insert the MDI into the spacer, shake 5–6×.
Exhale completely, then close your mouth around the spacer's mouthpiece.
Tilt head back slightly, press the inhaler, inhale slowly & deeply for 3–5 sec.
Hold breath 10 sec, remove mouthpiece, exhale through pursed lips.
It holds the medication in the device longer, which increases lung delivery and decreases the amount deposited in the oropharynx.
Enteral Tube (NG / Gastrostomy)
- Use liquid forms when available; never crush extended-release/enteric-coated/fluid-filled caps
- Give each med separately — never mixed with feedings
- Dissolve crushed tablets in 15–30 mL sterile water; verify tube placement first
- Flush before & after each med, ending with a 30 mL warm sterile-water flush
Parenteral
- TB/allergy testing — 0.1 mL, tuberculin syringe, 25–27g, 5°–15° angle, bevel up
- A small bleb should appear; don't massage the site
- Small doses of nonirritating water-soluble meds (insulin, heparin) — max 1 mL
- Abdomen/hips/arms/thighs; 45°–90° (90° if client is obese)
- 18–25g, 5/8–1.5 in, 90° angle; 1–3 mL (split larger volumes across 2 syringes/sites)
- Dorsogluteal no longer recommended (near sciatic nerve)
- IV opioid analgesia (morphine, fentanyl) via a catheter into the epidural space
- Infusion pump; monitor closely for hypotension
IM Site Selection — Safe Volume by Site
Pull the skin ~1 in laterally before inserting, inject, wait a beat, then release. When the skin snaps back it seals a zig-zag path through the tissue layers, trapping irritating/staining medication (e.g., iron) so it can't track back up into the subcutaneous tissue.
Three Calculation Methods, One Answer
Breeze finds that a client's home blood-pressure tablet is a higher concentration than the hospital's — so she's giving 2 tablets instead of the client's usual 1. Same total dose, different math. Getting comfortable converting between concentrations is exactly what these three methods are for.
- Always write the unit label next to every number (625 mg/tablet, not just 625)
- Identify: Desired (Rx dose), Have (concentration on hand), Quantity (per what unit), and frequency
- Round only at the very last step — never mid-calculation
- Sanity-check the number — 15 tablets for one dose? Re-verify or ask a colleague
- Leading zero: 0.7 mg, never .7 mg (a missed decimal = 10× overdose)
- No trailing zero: 7 mg, never 7.0 mg (a missed decimal = 10× overdose)
Same Problem, Three Roads — Phenytoin 0.2 g PO q8h · Available: 100 mg/capsule
- X cap = (1 capsule / 100 mg)
- × (1,000 mg / 1 g) — conversion factor
- × (0.2 g / 1) — the prescribed dose
- Convert first: 0.2 g = 200 mg
- 100 mg / 1 cap = 200 mg / X cap
- Cross-multiply: 100X = 200
- Convert first: 0.2 g = 200 mg
- X = (Desired ÷ Have) × Quantity
- X = (200 mg ÷ 100 mg) × 1 cap
Give 2 capsules PO q8h.
- Dimensional Analysis: X = (Have ÷ Dosage unit) × conversion factor(s) × Desired
- Ratio & Proportion: Have / Quantity = Desired / X
- Desired Over Have: X = (Desired ÷ Have) × Quantity
- Digoxin 250 mcg PO daily; have 0.125 mg/tablet
- Lisinopril 10 mg PO daily; have 2.5 mg/tablet
- Diltiazem 60 mg PO TID; have 20 mg/tablet
Rounding Rules — By the Device in Your Hand
Dosages < 1 → round to the nearest hundredth. Dosages > 1 → round to the nearest tenth. Look one digit to the right — ≥5 rounds up, <5 drops. Round only at the final step of a multi-step problem, never mid-conversion.
A calculated dose of 0.649 mL, rounded to the nearest hundredth, is 0.65 mL — the thousandths digit (9) is ≥5, so the hundredths digit rounds up from 4 to 5.
Rounding by Device in Hand
Whole, or half if scored — capsules can't split. 1.38 mg → 1.4 mg
Matches the oral syringe's increments. 1.5833 mL (0.1 mL syringe) → 1.6 mL
Matches syringe increments. 0.576 mL (0.01 mL syringe) → 0.58 mL
Almost always whole — some high-alert meds go to the tenth+. 0.375 mL → 0.4 mL
Depends on the pump. 16.77 mL/hr → 17 (whole-only) or 16.8 (tenth-capable)
Always whole — a partial drop can't be given. 37.5 gtt/min → 38 gtt/min
Dosage Calculations in Practice
Charles is giving acetylcysteine for acetaminophen toxicity. The vial is 20 mg/mL — but he misreads it as 10 mg/mL and gives double the intended dose. He catches his own error, immediately checks the client's vital signs, and pages the provider. Always read the concentration on the label itself — never assume it matches the last vial you drew up.
Worked Examples — Solid, Liquid, Injectable & Weight-Based
- Prescribed: 250 mcg PO daily
- Available: 0.125 mg/tablet
- Convert: 250 mcg = 0.25 mg
- Prescribed: 0.25 g PO q8h
- Available: 250 mg/5 mL suspension
- Convert: 0.25 g = 250 mg
- Prescribed: 8,000 units SUBQ q12h
- Available: 10,000 units/mL
- Convert: none needed
- Prescribed: 8 mg/kg/day ÷ q12h
- Weight: 22 lb = 10 kg
- Daily → per dose: 80 mg/day ÷ 2 = 40 mg
Body Surface Area (BSA) — Two Formulas
- 102 kg, 190 cm → 2.32 m²
- 96 kg, 172 cm → 2.14 m²
- 140 lb, 64 in → 1.69 m²
- 185 lb, 76 in → 2.12 m²
- 150 lb, 5'8" (68 in) → 1.80 m²
BSA dosing is reserved for medications with a narrow therapeutic window that need individualized dosing — chemotherapy and burn fluid resuscitation are the classic examples. Reassess often, since weight (and therefore BSA) changes over time.
Quick-Answer Drill Grid
Nystatin 400,000 units PO
4 mL
Gentamicin 6 mg/kg/day IM ÷3, 45 kg, 40 mg/mL
2 mL /dose
KCl 40 mEq in 6 oz water
180 mL water
Albuterol 3 mg PO q6h, 2 mg/5 mL
7.5 mL
Meperidine 150 mg SUBQ q6h PRN, 100 mg/mL
1.5 mL
Cefdinir 7 mg/kg PO q12h, 43 lb
137 mg
Acyclovir 5 mg/kg PO daily, 65 lb
148 mg
Amoxicillin 500 mg PO q6h, 500 mg/5 mL
1 tsp
Lisinopril 10 mg PO daily, 2.5 mg/tablet
4 tablets
Diltiazem 60 mg PO TID, 20 mg/tablet
3 tablets /dose
Haloperidol 2 mg PO q12h, 1 mg/tablet
2 tablets
Furosemide 80 mg PO daily, 10 mg/mL
8 mL
Heparin 15,000 units SUBQ q12h, 20,000 units/mL
0.8 mL
Amoxicillin 20 mg/kg/day ÷12h, 44 lb, 250 mg/5 mL
4 mL /dose
Haloperidol lactate 2 mg IM, 5 mg/mL
0.4 mL
Testosterone 75 mg IM weekly, 1,000 mg/5 mL
0.4 mL
Heparin 7,500 units SUBQ q12h, 5,000 units/mL
1.5 mL
Acetaminophen 650 mg PO, 325 mg/tablet
2 tablets
Acetaminophen 240 mg PR, 120 mg/suppository
2 suppositories
Hydrochlorothiazide 12.5 mg PO, 25 mg/tablet
0.5 tablet
Daily limit is 4 g (4,000 mg) in 24 hr across every source (Rx + OTC combo products) — exceeding it risks impaired liver function and hepatotoxicity.
IV Flow Rates — Pump & Gravity
Weight-Based Heparin — Convert Weight First, Round Last
- Prescribed: 60 units/kg IV bolus
- Weight: 160 lb = 72.73 kg
- Total dose: ≈ 4,363.6 units
- Available: 1,000 units/mL
- Prescribed: 20 units/kg/hr
- Weight: 170 lb = 77.27 kg
- Rate needed: ≈ 1,545.5 units/hr
- Available: 12,500 units/250 mL = 50 units/mL
Heparin is a high-alert medication — two nurses independently calculate the dose, and a second nurse verifies the drawn-up volume against the original order before it's given. PN scope of practice for high-alert meds like heparin varies by state/institution and is generally more limited than an RN's — always confirm facility policy before administering.
Quick-Answer Drill Grid
Ceftriaxone 1 g/100 mL over 30 min, 15 gtt/mL
50 gtt/min
0.9% NaCl 600 mL over 8 hr, 15 gtt/mL
19 gtt/min
D5W 500 mL over 6 hr, 60 gtt/mL
83 gtt/min
Vancomycin 1 g/100 mL over 45 min, 10 gtt/mL
22 gtt/min
Clindamycin 200 mg/100 mL over 30 min — pump
200 mL/hr
0.9% NaCl 250 mL over 30 min, 15 gtt/mL
125 gtt/min
Nitroprusside 2.5 mcg/kg/min, 55 kg, 50 mg/250 mL
41.3 mL/hr
IV Therapy — Access, Trade-Offs & Complications
- Rapid onset — 100% immediate absorption, most precise control
- Allows large volumes & poorly-soluble medications
- Dilutes irritating medications (e.g., chemotherapy)
- Immediate absorption = little time to correct an error
- Costly, inconvenient; risk of vein irritation
- Infection & embolism risk, especially with central lines
Access Type & Catheter Gauge
- Peripheral — short-term catheters, arm/hand veins preferred (ask the client's preference); newborns use head, lower-leg, or foot veins
- Central — long-term access: PICC, tunneled/non-tunneled catheters, implanted ports
- 16g — trauma
- 18g — surgery & blood administration
- 22–24g — children, older adults, or a stable postoperative client
- Add meds to a new IV container — never one already hanging
- Never through tubing infusing blood, blood products, or TPN
- Verify compatibility before infusing through existing tubing; use the port closest to the client
- Wipe every port with antiseptic before connecting
- Older adults/anticoagulants/fragile veins: distend veins with a BP cuff (not a tourniquet), avoid slapping the extremity, hold the hand below heart level, avoid the back of the hand
- BMI > 30: use IV placement aids/ultrasound guidance
Four Complications to Catch Early
- Findings: Pallor, local swelling, ↓ skin temp, damp dressing, slowed infusion
- Treatment: Stop infusion, remove catheter, elevate extremity, cold or warm compress depending on solution, restart proximal/other extremity if still needed
- Prevention: Careful site/catheter selection, secure catheter, frequent inspection
- Findings: Pain, burning, redness, swelling
- Treatment: Stop infusion, notify provider immediately — protocol may include withdrawing the vesicant + antidote before removal
- Prevention: Closely monitor the site & dressing
- Findings: Distended neck veins, ↑BP, tachycardia, SOB, crackles, edema
- Treatment: Slow/stop infusion, raise HOB, monitor VS/O2 sat, anticipate diuretics
- Prevention: Use an infusion pump, monitor I&O
- Findings: Edema, erythema, throbbing/burning pain, ↑ skin temp, palpable red line up the arm
- Treatment: Stop & remove catheter promptly, elevate, cold then warm compress, culture if drainage present
- Prevention: Smallest appropriate gauge, phlebitis scale monitoring, avoid lower extremities, clean technique
Other complications: catheter embolus, cellulitis, air embolism — treat per facility protocol. Any complication requires provider notification + complete documentation; use new tubing/catheter when restarting.
Building a Culture of Safety
Josie's pharmacy label maker goes down mid-shift — all labels get handwritten with no barcode to scan. She administers IV diphenhydramine to the wrong client. No harm occurs, but it's a real error that reached the client — an adverse drug event (ADE), any injury from a medication (preventable, like this one, or nonpreventable, like an unavoidable allergic reaction) — exactly the kind of gap these systems exist to close.
4 Sources of Medication Errors
Bart's preceptor once showed him a shortcut that skipped a technology safeguard "to save time." Believing he was helping, Bart used it — and gave the wrong medication to the wrong client. Never bypass CPOE, BCMA, or a CDSS alert as a workaround, even under time pressure.
History → Technology — How the System Learned to Catch Errors
IOM report: 44,000–98,000 deaths/yr, $17–29B/yr from preventable errors — most from system failures, not bad individuals. Recommended a National Center for Patient Safety to drive a "culture of safety."
6 competencies: Client-Centered Care, Teamwork, EBP, Quality Improvement, Safety, Informatics.
w/ DoD Patient Safety Program, adopted by the American Hospital Association; 4 pillars: Communication (SBAR), Mutual Support (CUS), Leading Teams, Situation Monitoring (STEP).
Computerized orders + decision-support alerts for interactions, dosage, omissions.
Barcode-scan the client, then the medication, against the eMAR before giving it.
The Joint Commission bans dangerous abbreviations facility-wide.
"Do Not Use" Abbreviations
| Do Not Use | Use Instead | Do Not Use | Use Instead |
|---|---|---|---|
| U, u | "Unit" | MSO4, MgSO4 | "Magnesium sulfate" |
| IU | "International Unit" | MS | "Morphine sulfate" |
| Q.D., QD, q.d., qd | "Daily" | Q.O.D., QOD, q.o.d., qod | "Every other day" |
Near Miss vs. Sentinel Event — Same Slip, Different Path
The Swiss Cheese Model — Organizational Version (Reason)
A different lens than a single practice slip: 4 organizational layers, each a slice of cheese with its own holes. Example — a heparin adverse drug event:
The client received only normal saline, not the heparin — the final, human-factor slip directly tied to the outcome.
Policy requires a second nurse to verify the rate — that step was skipped, letting the wrong rate initiate.
Insufficient supervision let a brand-new nurse work unsupported and hang the wrong medication.
A dormant systemic gap — inadequate training on new equipment — that set the whole chain in motion.
Active failures = unsafe acts happening in real time, human-factor-linked, directly causing the bad outcome. Latent failures = dormant systemic problems that can sit undetected for months until they line up with everything else.
Why Errors Go Unreported — & What Fixes It
- Fear of blame, punishment, or job loss
- Fear of legal consequences or loss of respect
- Weak safety culture; unclear definition of "error"
- Overly complicated reporting process
- Establish effective communication protocols
- Stay current on procedures/equipment; use EBP
- Manage workload & staff burnout
- Implement ID, fall, sharps & violence-prevention protocols
Exam High-Yield Summary
Most critical moment to verify the right dose
Immediately before administering to the client
CDSS dosage alert for an elderly client
Review the alert + consult the prescriber to adjust if necessary — don't override or dismiss it
True purpose of reporting medication errors
Improve systems & processes — not to assign blame
Discovering you made an error
Complete the facility's designated error report form
Order missing a route
Contact the prescriber before administering — never assume PO or IV
Client received 2× their BP med dose
Immediate priority: monitor vital signs
Sentinel event next step
Notify risk management to report to The Joint Commission
Purpose of tall-man lettering
Highlights the distinguishing part of a look-alike drug name
Route on the order differs from expected
Verify the route on the order before giving it
First action to improve practice after an error
Report through the facility's incident reporting system
BCMA — next step after scanning the wristband
Scan the medication barcode to confirm it matches the eMAR
Multiple safety barriers failed at once
Implement verification at every step of administration
Unfamiliar abbreviation on an order
Contact the prescriber to confirm its meaning
MAR doesn't match the prescription
Contact pharmacy to clarify — don't edit the MAR yourself
RCA "swiss cheese" layer for system-wide change
Organizational influences — policies, procedures, resource allocation
SATA — first-dose new medication actions
Monitor VS at intervals · evaluate therapeutic effect · observe for condition changes (not "wait" and not "let it work" before follow-up)
Spotting a drug-drug interaction before giving
Contact the provider to discuss + get instructions
High-risk/precise-dose medication
Verify the calculation with a second nurse or pharmacist
ANA action that most reduces admin errors
Establish communication protocols for handoffs
New order + client on multiple meds
Review the current med list for contraindications first
Long-standing supply-drawer mislabeling → error
A latent failure (vs. an active failure = the immediate human action)
Med available PO & IV, order specifies PO
Give the oral form per the order — never substitute routes
Reviewing an order, dose looks wrong
Contact the prescribing provider to clarify — don't skip or silently adjust
QSEN's 6 competencies
Client-Centered Care · Teamwork & Collaboration · EBP · Quality Improvement · Safety · Informatics
AHRQ/TeamSTEPPS 4 core principles
Communication · Mutual Support · Leading Teams · Situation Monitoring
Documenting a near miss
File the incident report per policy — never reference it in the client's medical record
"To Err Is Human" headline stat
44,000–98,000 preventable-error deaths/yr sparked systems-based reform (EHR, CPOE, BCMA)
True benefit of CPOE
Reduces transcription errors from illegible handwriting — not fewer prescriptions or more workarounds
High-alert med double-check rule
Independent double-check + cosignature at the bedside (insulin, anticoagulants, opioids, neuromuscular blockers)
IV initiation, older adult w/ fragile veins
Distend veins using a blood pressure cuff — not a tourniquet
Client having an allergic reaction right now
Assess reaction severity and follow the facility's emergency protocol — don't just reassure or wait for the provider
Minor error realized wasn't reported at the time
Report it retrospectively — late reporting still beats no reporting
Documenting a client's weight
Always in kilograms — the unit every weight-based dosage formula expects
Clinical Judgment & Medication Administration
The 6-step Clinical Judgment Measurement Model applied to real medication decisions, how pediatric/older-adult/pregnancy physiology reshapes dosing, the Beers/KIDs/PLLR safety lists, incompatibility vs. drug-drug interactions, and the step-by-step mechanics of reconciling, administering, and monitoring medications safely.
The Clinical Judgment Model
Marcy, 67, is at her provider's office for seasonal allergies. She's still taking her PCP's medications (including cetirizine PRN) and has an updated list from her cardiologist. The nurse tells her they'll need to review all medications and doses together to check for interactions — that review process is clinical judgment in action.
Clinical judgment is the process of using critical thinking and decision-making to assess, plan, and provide appropriate care. It blends knowledge, experience, intuition, and client-specific factors — letting nurses adapt care to each client rather than applying one script to everyone. It's built from the same bones as the nursing process, but is explicitly framed as an ongoing, circular cycle, not a line with an end.
The Six-Step Cycle — Richard's Asthma Exacerbation
Foundational — collect data (vitals, history, manifestations). No hypotheses yet. Richard, 8, asthma: reviews his mild-intermittent-asthma history, learns he has a PRN albuterol rescue inhaler, performs a respiratory assessment + vitals/pulse ox, and asks when he last used the inhaler and whether it helped.
Check for risks; identify which findings are consistent (or not) with a specific condition. Richard: last dose 4 hr ago, partial relief; SpO₂ 93% RA, RR 26/min, diffuse wheezing, retractions, minimal speech. Vitals outside the expected range → poor oxygenation, consistent with asthma exacerbation.
Use a prioritization framework; identify the client's most urgent needs with the team. Richard: diagnosed with acute asthma exacerbation; provider orders a STAT nebulized albuterol + STAT systemic corticosteroid. Nurse prioritizes prompt administration given the acuity and STAT order.
Interprofessional plan — desired outcomes, positive/negative impacts, interventions to avoid. Richard: older child → mouthpiece nebulizer (not a face mask, which is for infants/young children); gathers supplies; plans to have Richard watch for misting and take slow, deep breaths.
Implement by priority; document; coordinate care; monitor the client's response. Richard: nurse administers the nebulizer treatment, documents time/dose/route immediately, reassesses, and tells the family monitoring will continue closely — including HR/BP (albuterol effect) and repeat respiratory checks.
Reassess: improving, worsening, or unchanged? Feeds directly back into new cues. Richard: RR 21/min, SpO₂ 96% RA, clear lungs, no retractions, relaxed and conversing comfortably → improved. Discharge prep begins: asthma action plan, spacer teaching, when to seek care.
Evaluating outcomes triggers new assessments, new priorities, and new solutions. The cycle keeps running.
A nurse planning to monitor a client for manifestations of a drug-drug interaction is performing the Generate Solutions step — deciding how to watch for a problem is part of planning the solution, not just recognizing or analyzing the cue.
Medications Across the Lifespan
Cherie, 70, is admitted for heart failure exacerbation with a history of hypertension and diabetes. Her age-related decreased renal function and altered drug metabolism make her more vulnerable to medication complications — the team adjusts her dosages for these pharmacokinetic changes and monitors closely for toxicity (confusion, dizziness).
A client's stage of life significantly changes how medications are absorbed, distributed, metabolized, and excreted. Understanding age-related PK/PD changes lets nurses recognize the need for an individualized regimen — proper dosage adjustments and monitoring based on these factors minimize the risk of adverse drug reactions.
Pediatric, Older Adult & Pregnancy/Lactation
Dosing: Usually weight-based. Body size, metabolic rate, body-water content & organ maturity all alter PK/PD. Neonates have a higher gastric pH than older infants — may need dosage adjustment for acid-dependent meds.
Formulation: Liquid forms common (inability to swallow tablets). Consider concentration, ease of measuring, taste, and storage.
Monitoring: Track growth parameters, weight changes, developmental milestones. Adverse reactions are more common than in adults; children may not verbally express symptoms.
Dosing: Age-related ↓ hepatic & renal function affects metabolism/excretion. Reduced liver mass and renal function often require dose reduction to prevent toxicity.
Formulation: Consider vision & dexterity changes; swallowing difficulty → select easy-to-swallow forms.
Monitoring: Multiple comorbidities → watch for drug-drug interactions and monitor drug levels/therapeutic effect. ↑ sensitivity can mean more severe ADRs at lower doses.
Dosing: ↑ Progesterone decreases gastric motility, delaying GI transit and affecting absorption. ↑ Blood volume/plasma expansion change volume of distribution. ↑ GFR increases renal clearance.
Formulation: Oral absorption is largely unaffected; parenteral & inhaled meds have increased absorption.
Monitoring: Placental transfer depends on solubility/protein binding — many meds are teratogens to avoid. Watch the infant for sleepiness, GI signs, or breathing/rash/heart-rate changes.
Pediatric weight (kg) ÷ 68 kg × Standard adult dose = Pediatric dose
Assess the infant's growth pattern & health status · educate on timing doses around breastfeeding schedules · consult the team about nonsystemic alternatives · monitor the client's health/nutritional status. Not correct: instructing the client to only take pregnancy-labeled meds, or discontinuing breastfeeding outright.
Applying Clinical Judgment — Formulations
- Recognize Cues: collaborate with client/provider to spot data suggesting an alternate formulation is needed
- Analyze Cues: determine the client's ability to take the medication as prescribed (e.g., swallowing difficulty)
- Prioritize Hypotheses: select the formulation matching the client's specific needs
- Generate Solutions → Take Action → Evaluate Outcomes: build the medication plan, implement/teach it, then monitor for effectiveness and tolerance
Polypharmacy, the Beers List & the KIDs List
Polypharmacy is the concurrent use of multiple medications — often defined as 5 or more. It's common in older adults with several chronic conditions, and it can even be intentional (a laxative prescribed to offset an opioid's constipating side effect). Other drivers: multiple prescribers, multiple diagnoses. Risks: adverse effects, drug-drug interactions, nonadherence, and higher healthcare costs. The nurse's role — regularly reassess the med list for appropriateness, educate the client, watch for ADRs, and evaluate regimen effectiveness.
Most common among clients with multiple comorbidities/complex diagnoses — compounds a population that already has higher baseline ADR rates.
Cognitive impairment can cause nonadherence/administration errors. More medications = higher interaction likelihood. ↑ ADR risk — falls (sedatives), orthostatic hypotension (antihypertensives).
Pregnancy/lactation polypharmacy is rising (obesity, rising maternal age). New pregnancy-related prescriptions stack onto preexisting-condition regimens, raising interaction/nonadherence risk — with extra focus needed on fetal/infant impact.
Management Strategies
- Frequent medication reconciliation — update & verify the list at every transition of care
- Providers evaluate the need for each medication and consider deprescribing (tapering/discontinuing unnecessary meds)
- Layer in nonpharmacological interventions (lifestyle modification) alongside medications where possible
- Simplify regimens — pill organizers/boxes help clients navigate numerous medications and stay adherent
Reviewing an older adult's medication list for polypharmacy — the most appropriate action is to review the list for potential interactions, not to stop all OTC meds, simply encourage continuation, or mandate a single pharmacy.
Beers Criteria vs. KIDs List
Evaluating medication formulation for an older-adult client post-stroke → assess the client's ability to swallow (not crushing everything, requesting IV-only, or just weighing the client).
"Recognizing cues" for pediatric polypharmacy → checking the full medication list (prescriptions + supplements + OTC) — analyzing for adverse effects would be the next step, Analyze Cues.
Pregnancy & Lactation Labeling Rule (PLLR)
Pregnancy and lactation require careful consideration of medication safety for both the client and the fetus/infant — use varies widely based on the client's health conditions. The FDA built a labeling system to help providers and clients make informed decisions.
- Pregnancy: Risk summary + supporting data, including pregnancy exposure registries & clinical studies
- Lactation: Effects on the breastfeeding infant + impact on milk production/quality
- Reproductive Potential: Information relevant to females & males of reproductive potential
PLLR labeling applies to medications developed after the 2015 regulation. Medications already in circulation only get updated labels if there's a change in indication for use — otherwise, they may still carry the old A/B/C/D/X category.
Explaining PLLR to a concerned client — the correct teaching point is that labels explain risks and benefits using clinical-study and pregnancy-exposure-registry data, not a simple risk-letter category, a standardized FDA checklist, or a mandated pharmacist consult.
Medication Incompatibility & Drug-Drug Interactions
Sam, 35, has epilepsy and starts a new anticonvulsant while regularly taking an OTC pain reliever for chronic back pain. The combination decreases the anticonvulsant's effectiveness, causing breakthrough seizures. The nurse identifies the drug-drug interaction and recommends alternative pain management to protect seizure control.
Two Kinds of Incompatibility
Both types alter a medication from its original form. Effects range from mild (↓ efficacy) to severe adverse drug events — pulmonary embolus, shock, organ failure. Drug interaction tools, medication guides, package inserts, and nursing expertise all help catch incompatibilities before they happen.
Drug-Drug Interactions — Two Mechanisms
One med changes another's absorption (antacids ↓ absorb certain antibiotics), metabolism (liver enzyme induction/inhibition), or excretion (altered renal clearance).
Two meds acting on the body together create an additive effect — the combined effect is greater than either alone.
Identify interactions using the Drug Interaction Database, EHR built-in interaction alerts, or by consulting the pharmacist. Effects on the client can include ↑ ADR risk (synergistic/antagonistic/additive), toxic elevated levels, ↓ effectiveness (worsening or prolonging illness), and generally more complicated treatment adherence.
Match the Statement to the Interaction Type
| Statement | Interaction Type |
|---|---|
| Absorption, metabolism, or excretion of a medication is affected. | Pharmacokinetic Interaction |
| A visible reaction occurs — precipitation, color change, turbidity. | Physical Incompatibility |
| Medications react and alter each other's structure or function. | Chemical Incompatibility |
| Adverse reactions, reduced efficacy, or increased side effects occur. | Drug-Drug Interaction Outcome |
| Two medications combined create an additive effect. | Pharmacodynamic Interaction |
Client on a hepatic enzyme inhibitor — to reduce ADR risk, the nurse should monitor for manifestations of reduced efficacy of medications metabolized by the liver, not increase dosages or disregard the interaction after recent labs.
To ensure compatibility of newly prescribed medications, consult the drug interaction database before administering — never give two medications together just "to see," and don't rely on history or allergy questions alone.
Check the most recent INR · notify the provider about ongoing bleeding · review the medication list for interactions · ask about recent dietary changes (vitamin K intake). Never encourage forceful nose-blowing.
The Engage video "Clinical Judgment and SBAR: Addressing Medication Adverse Reactions" reinforces that the SBAR framework is the standard way to hand off a suspected drug-drug interaction or ADR to the provider.
Steps of Medication Reconciliation
During discharge planning, a nurse notices the discharge prescriptions for a 65-year-old man (admitted for a respiratory infection, given antibiotics + bronchodilators) are missing his chronic hypertension and diabetes medications. She contacts his PCP, and the team confirms the chronic medications continue alongside the new hospital prescriptions.
Medication reconciliation is a systematic safety process comparing a client's current medication list against new prescriptions, hospital orders, or discharge instructions — catching omissions, duplications, and dosing errors. Its purpose is fundamentally to identify duplicate medications (not to discourage OTC use, save the nurse time, or cut costs). It should happen during every transition of care — between medical settings (including home health), when providers change, and at individual office visits.
Building the Reconciled List
Encourage clients to carry their own list — handwritten or via a smartphone app.
Cross-check dose, frequency & accuracy against documented orders.
If no reliable list exists, the dispensing pharmacy can supply one.
The Four Steps
Get a complete & accurate list of every current medication.
Validate the list in the medical record — verify adherence with open-ended questions like "How do you take your medications?"
Identify omissions/duplicates/dosage changes against the home or transferring-facility list, using clinical judgment to add, remove, or edit.
Tell the client and full team about changes, educate on new/changed medications, and finalize the documented list.
A client transferred from acute care to long-term care — the correct action is to compare the admission prescriptions with the list from the transferring facility, not simply administer per the transfer list or rely on the client's verbal report.
Applying Clinical Judgment — Newly Prescribed Medications
- Recognize Cues: collect client + record data; update the record with newly prescribed medications
- Analyze Cues: check the full list for duplicates/omissions; compare current vs. newly prescribed meds
- Prioritize Hypotheses: identify potential interactions between new and current medications
- Generate Solutions → Take Action → Evaluate Outcomes: plan client education, implement teaching (ADRs to report, administration method), then follow up on efficacy
Principles of Medication Administration
Jo is hospitalized for pneumonia and prescribed a broad-spectrum antibiotic. Before giving it, the nurse confirms it's indicated for pneumonia, notices Jo's renal-impairment history, and asks the provider to confirm the dose accounts for her renal function. The provider confirms the dose is correct — preventing a potential adverse effect.
A Medication's Dossier — Built From Jo's Case
| Category / Class | Pharmacological action + therapeutic use + body-system target + pregnancy classification. Ex: lisinopril = ACE inhibitor (action) & antihypertensive (use). |
| Mechanism of Action | How the medication produces its effect at the cellular/molecular level (receptors, enzymes, ion channels). Ex: glipizide stimulates pancreatic islet cells to release insulin. |
| Indications | The reason(s) for use — ensures the right medication for the right clinical reason. Jo's antibiotic is indicated because her diagnosis is pneumonia. |
| Contraindications | Conditions/factors making a medication unsafe — known allergies, specific conditions, drug interactions. Verify history before administering. |
| Precautions | Considerations short of a contraindication for certain populations. Jo's renal impairment is a precaution requiring provider dose confirmation. |
| Therapeutic Effect | The expected response the medication is given for — one medication can have more than one. Ex: diphenhydramine for allergies vs. for sleep. |
| Side Effects | Known, expected, usually-mild secondary effects at a therapeutic dose. Ex: antibiotics causing diarrhea. |
| Adverse Effects | Undesirable, harmful, unexpected responses — can occur at therapeutic or toxic doses, immediately or after weeks/months. Ex: gentamicin causing hearing loss. |
| Toxic Effects | Develop after prolonged use or when toxic amounts build up from faulty metabolism/excretion. Ex: digoxin toxicity → dysrhythmias, worsened by hypokalemia. |
| Medication Interactions | Beneficial (atenolol + nifedipine preventing reflex tachycardia) or harmful (omeprazole + phenytoin → ↑ phenytoin level) — obtain a complete history, including food/herbal/supplement interactions. |
| Preparation / Dosage / Route | Prep, safe-dose range, calculations, and administration considerations. Ex: oral morphine doses run higher than parenteral due to extensive first-pass effect. |
| Nursing Implications | Know how to monitor therapeutic/adverse effects, prevent and treat ADRs, provide comfort, and instruct the client on safe use. |
Mechanism of action also informs route selection — a client who struggles to remember a daily oral pill may be switched to a transdermal patch instead, if one is available for that medication.
Applying Clinical Judgment — Administration
- Recognize Cues: client identifiers, allergy/history review, compare medication to the prescription, needed assessments
- Analyze Cues: determine whether a contraindication exists (allergy, anomalous finding)
- Prioritize Hypotheses: if administration is indicated, prioritize monitoring, follow-up assessment & teaching needs
- Generate Solutions → Take Action → Evaluate Outcomes: plan administration + supplies + education, administer & teach, then evaluate response and understanding
Rights & Routes — Quick Safety Check
The Engage podcast "Spotlight on the 10 Rights" frames each right as the nurse's final safety check before a medication reaches the client — including the client's Right to Refuse. Practice-test hit: if a client refuses, document the refusal and notify the prescriber — never administer anyway or omit the documentation.
The 10 Rights — Quick Recap
- Right Client — two identifiers, every time.
- Right Medication — confirm the label matches the order/prescription.
- Right Dose — verify against a safe-range reference; double-check high-alert meds.
- Right Time — within 30 minutes of the scheduled time.
- Right Route — matches the prescription; appropriate for the client's condition.
- Right Documentation — record immediately after giving, never before.
- Right Education — clear, concise teaching reinforced with teach-back/return demonstration.
- Right to Refuse — respect it, document it, notify the prescriber.
- Right Assessment — e.g., assess pain level with a pain scale before an opioid.
- Right Evaluation — did the client get the intended therapeutic effect, without an undesired response?
Routes — Quick Map by Category
Oral · Sublingual · Buccal
Topical · Transdermal
Ophthalmic · Otic · Nasal · Rectal · Vaginal
MDI · DPI
NG / Gastrostomy Tube
Intradermal · Subcutaneous · Intramuscular · IV · Epidural
Full nursing steps, positioning & angles for every route → Reading 3.
Monitoring Therapeutic & Adverse Effects
Before / During / After
Baseline vitals/labs, allergy check, contraindication review, and pertinent assessments (e.g., pain level before an analgesic).
Watch for an immediate reaction; monitor infusion rate for IV meds; assess comfort and tolerance.
Reassess for therapeutic response and ADRs at the appropriate interval; document; communicate findings; plan follow-up.
Indications of a therapeutic effect vary by medication — reduced/resolved manifestations, increased functionality, stabilization, or prevention. Nurses assess this via vitals, labs, and client-reported change, then document and communicate findings, while also evaluating adherence to the regimen.
Adverse effects can stem from client factors, drug-drug interactions, medication errors, or incorrect dosing. Nursing responsibilities: ongoing assessment before/during/after administration; client education on what to report; prompt, accurate documentation (informs the whole care team and tracks safety); reporting significant ADRs through appropriate channels/safety databases; and regular follow-up reassessment.
A client experiencing an adverse effect from a new blood-pressure medication — the nurse's first action is to monitor the client's vital signs, before documenting, notifying the provider, or teaching about potential effects.
A newly admitted client's history lists hypertension, diabetes, seasonal allergies, and atrial fibrillation — this combination raises the odds of additive antihypertensive/antiarrhythmic effects (hypotension, bradycardia) and antihistamine-driven anticholinergic/CNS effects layered on existing conditions.
Applying Clinical Judgment — Monitoring Effects
- Recognize Cues: monitor the client during/after administration, including vitals and physical condition
- Analyze Cues: determine whether findings indicate an adverse reaction
- Prioritize Hypotheses: rank findings by relative risk to decide which intervention comes first
- Generate Solutions: for an ADR, plan interventions in priority order — stop the medication, notify the provider, give reversal agents if applicable
- Take Action → Evaluate Outcomes: implement interventions in order, document once stable, report serious events, then evaluate the client's response
Administering Medications — Oral & Enteral
Medication administration is a major nursing responsibility — a high-frequency skill reported to make up up to 40% of the nurse's workload. Oral medications are the most commonly prescribed type; buccal and sublingual forms are not swallowed — they absorb directly through the oral mucosa into systemic circulation, fast. An enteral feeding tube (EFT) — a surgically placed gastric tube or a nasogastric tube — is used when a client can't absorb nutrition/medications normally through the GI tract or can't take them by mouth; the nurse must verify medication compatibility with the EFT and confirm tube placement before giving anything through it. An RN can delegate either skill to another RN or a competency-verified LPN, per facility policy and the state Nurse Practice Act — never to assistive personnel, and the delegating nurse remains responsible for the outcome.
Allergy check → verify identity with 2 identifiers → hand hygiene + PPE → privacy & introduction → confirm the prescription/order → follow the 10 rights → document immediately after giving.
Oral vs. Enteral Tube
- Position: Upright, high-Fowler's, or side-lying — reduces aspiration risk and eases swallowing.
- Can't swallow? Consult a reference/pharmacist before crushing a tablet or opening a capsule into applesauce — not everything can be safely crushed.
- Pills: Medication cup → water → client swallows each pill → observe swallowing → check the mouth to confirm.
- Buccal / Sublingual: Cheek-and-gum or under-the-tongue placement; do not swallow until fully dissolved.
- Liquids: Shake first → pour to the meniscus at eye level on a flat surface → oral syringe if needed → observe swallowing.
- Stay at bedside: Never leave medication unattended — a client may "pocket" a pill after the nurse leaves.
- Client considerations: Unilateral weakness → stronger side, one pill at a time. Pediatric → spoon/syringe/dropper for liquids.
- Vomiting: Do not immediately repeat the dose — contact the provider.
- Choking/aspirating: Follow the basic life support choking algorithm.
- Position: Head of bed ≥30° unless contraindicated — reduces aspiration risk.
- Pause tube feeding: Per facility policy/med recommendations — some feedings alter drug bioavailability.
- Verify placement: Check per facility protocol for that EFT type before anything else.
- Check GRV: High residual (250–500 mL) may suggest intolerance, but current guidance does not support stopping feedings for high GRV alone.
- Flush first: 30 mL water via gravity, using a ≥30 mL enteral-only syringe — never an IV syringe.
- Give each dose: Fully dissolve crushed tablets/capsule contents in 15–30 mL sterile water; give separately, never mixed together or with feedings.
- Flush between doses: 15–30 mL water between every medication to maintain patency.
- Flush after the last dose: 30–60 mL water, then clamp, remove the syringe, cap the tube, and restart feeding per policy.
- Occlusion: Flush with warm water/alkalinized enzyme/carbonated water using a push-pull technique; notify the provider if still obstructed.
Documentation & Equipment
Date/time · nurse's initials/signature · medication, dose & route · pertinent pre-admin findings (e.g., apical HR before digoxin) · education given · client's response · unexpected outcomes + provider notification
Gloves/PPE · MAR · medication · graduated med cup/oral syringe · water · pill crusher + soft food if crushing · spoon
Gloves/PPE · MAR · medication · irrigation kit · medicine cup · 60-mL enteral syringes · sterile water (dissolves + flushes — tap water may be contaminated) · towel/pad
Exam High-Yield Summary
Purpose of medication reconciliation
To identify duplicate medications — not to discourage OTC use, save nurse time, or cut hospital costs
Right Time — routine scheduled medication
Administer within 30 min of the prescribed/scheduled time
Medication incompatibility teaching point
Chemical incompatibilities occur at the molecular level
Adverse effect example
Hives after taking an opioid for pain control
Med rec — acute care → long-term care transfer
Compare the admission prescriptions with the transferring facility's list
Client refuses a medication
Document the refusal and notify the prescriber
Medication admin across the lifespan
Pediatric dosages are usually based on the child's weight
Beers List teaching point
Anticoagulants are on the list due to increased bleeding risk
Medications in infants — teaching point
Newborns have a higher gastric pH than older infants, possibly requiring dosage adjustment
Medications during pregnancy — teaching point
↑ Progesterone decreases gastric motility, affecting absorption
Medications across the lifespan — true statement
Adverse reactions are more common in pediatric clients than in adults
Adverse effect from a new BP med — first action
Monitor the client's vital signs
Diuretic client — ↑ urinary output 1 hr post-dose
This is the nurse performing Right Evaluation
Before administering oxycodone
Assess pain level using an appropriate pain scale
Admitting a client — prioritize med safety
Verify use of OTC medications or supplements
Client on a hepatic enzyme inhibitor
Monitor for reduced efficacy of hepatically metabolized medications
Ensuring compatibility of new medications
Consult the drug interaction database before administering
Medication reconciliation on admission
Should be performed during transitions of care
New tachycardia medication — therapeutic effect
Heart rate is within the expected range
Ensuring the correct medication is given
Confirm the label matches the order/prescription
Medication reconciliation — first step
Obtain a complete, accurate list of all current medications
SATA — safe medication teaching principles
Correct dosage/frequency · monitor & report side effects — not altering dose by comfort, food-with-everything, or herbal substitution
Nurse plans to monitor for a drug-drug interaction
This is the Generate Solutions step of the clinical judgment process
Gastrointestinal System
Flashcard-style medication notes for antiemetics, bowel-disorder therapies, and GI-disorder medications. Click a card to flip it — the answer leads with the six essentials before the supporting detail.